Expertos

PUBLICACIONES DESTACADAS
LIBROS:
Progresos en Hepatología
Avances en Gastroenterología
Hígado, vías biliares y páncreas
Enfermedades hepáticas crónicas no alcohólicas

además de numerosos capítulos de libros

PREMIOS Y OTROS MÉRITOS

Becaria de la Fundación Clínic para el desarrollo del proyecto titulado "Estudio molecular del Carcinoma Ductal Pancreático" (Ref. 6-03/156) dentro del Instituto de investigación Biomédicas August Pi i Sunyer (IDIBAPS) en el Servicio de Gastroenterología del Hospital Clínic de Barcelona, España

Publicaciones en revistas indexadas

1. Ana C. Adet Caldelari, Josa Miquel, Joan Antoni Bombi, Angel Ginés, Gloria Fernandez-Esparrach, Carmen De Juan, Juan Ramón Ayuso, Joan Maurel, Faust Feu, Antoni Castells, Laureano Fernández Cruz, Salvador Navarro. Predictive factors of malignancy in the intraductal papillary mucinous neoplasm of pancreas. Medicina Clinica (Barcelona) 2011;137 (14):631-636.
2. Ana Adet, Rosa Miquel, Joseph A. Bombi, Angels Ginés, Gloria Fernández-Esparrach, Carmen De Juan, Juan R Ayuso, Joan Maurel, Antoni Castells, Laureano Fernández-Cruz, Salvador Navarro. Incidence and characteristics of the cystic neoplasms of the pancreas. Gastroenterol Hepatol 2010;33(8):563-568.
3. Antonio Soriano-Izquierdo, Ana C. Adet, Rosa Gallego, Rosa Miquel, Antoni Castells, María Pellisé, Cristina Nadal, Miguel A. López-Boado, Josep M. Piqué, Pere Gascón, Carles Conill, Antoni Bombi, Laureano Fernández-Cruz, Joan Laurel y Salvador Navarro. Prediction of prognosis of patients with pancreatic adenocarcinoma resected with curative intent through histological grade and the pathological N status. Medicina Clínica (Barcelona) 2009; 132(5):163-171.
4. Salvador Navarro, Ana C. Adet. Tests of exocrine pancreatic function. Gastroenterología y Hepatología continuada. 2004; volume 3, number 5:222-227.

Publicaciones en revistas indexadas

Haberman DM, Andriani OC, Segaran NL, Volpacchio MM, Micheli ML, Russi RH, Pérez Fernández IA. Role of CT in Two-Stage Liver Surgery. Radiographics. 2022 Jan-Feb;42(1):106-124. doi: 10.1148/rg.210067. PMID: 34990325.

Ignatavicius P, Oberkofler CE, Chapman WC, DeMatteo RP, Clary BM, D'Angelica MI, Tanabe KK, Hong JC, Aloia TA, Pawlik TM, Hernandez-Alejandro R, Shah SA, Vauthey JN, Torzilli G, Lang H, Line PD, Soubrane O, Pinto-Marques H, Robles-Campos R, Boudjema K, Lodge P, Adam R, Toso C, Serrablo A, Aldrighetti L, DeOliveira ML, Dutkowski P, Petrowsky H, Linecker M, Reiner CS, Braun J, Alikhanov R, Barauskas G, Chan ACY, Dong J, Kokudo N, Yamamoto M, Kang KJ, Fong Y, Rela M, De Aretxabala X, De Santibanes E, Mercado MÁ, Andriani OC, Torres OJM, Pinna AD, Clavien PA. Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice? Ann Surg. 2020 Nov;272(5):715-722. doi: 10.1097/SLA.0000000000004331. PMID: 32833764.

Mendizabal M, Rowe C, Pinero F, Gonzalez-Campana A, Fauda M, Tomás Arufe D, Pía Raffa M, Barreiro M, Keller R, Cacheiro F, Beruti E, Andriani O, Oscar Silva M, Podestá LG. Successful orthotopic liver transplantation and delayed delivery of a healthy newborn in a woman with fulminant hepatic failure during the second trimester of pregnancy. Ann Hepatol. 2014 Mar-Apr;13(2):288-92. PMID: 24552872.

O Connor JM, Sanchez Loria F, Ardiles V, Grondona J, Sanchez P, Andriani O, Fauda M, Brancato F, Huertas E, Alvarez F, de Santibanes E. Prognostic impact of K-RAS mutational status and primary tumor location in patients undergoing resection for colorectal cancer liver metastases: an update. Future Oncol. 2019 Sep;15(27):3149-3157. doi: 10.2217/fon-2019-0196. Epub 2019 Aug 20. PMID: 31426677.

Andriani OC. Long-term results with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg. 2012 Sep;256(3):e5; author reply e16-9. doi: 10.1097/SLA.0b013e318265fbbe. PMID: 22842129.

Pinero F, Marciano S, Anders M, Orozco F, Zerega A, Cabrera CR, Bana MT, Gil O, Andriani O, de Santibanes E, McCormack L, Gadano A, Silva M. Screening for liver cancer during transplant waiting list: a multicenter study from South America. Eur J Gastroenterol Hepatol. 2015 Mar;27(3):355-60. doi: 10.1097/MEG.0000000000000272. PMID: 25563142.

Pinero F, Fauda M, Quiros R, Mendizabal M, González-Campana A, Czerwonko D, Barreiro M, Montal S, Silberman E, Coronel M, Cacheiro F, Raffa P, Andriani O, Silva M, Podestá LG. Predicting early discharge from hospital after liver transplantation (ERDALT) at a single center: a new model. Ann Hepatol. 2015 Nov-Dec;14(6):845-55. doi: 10.5604/16652681.1171770. PMID: 26436356.

Pinero F, Marciano S, Anders M, Orozco Ganem F, Zerega A, Cagliani J, Andriani O, de Santibanes E, Gil O, Podestá LG, McCormack L, Gadano A, Silva M. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina. Eur J Gastroenterol Hepatol. 2016 Apr;28(4):421-7. doi: 10.1097/MEG.0000000000000551. PMID: 26684693.

Publicaciones en revistas indexadas

Mesotelioma maligno de peritoneo. Causa infrecuente de síndrome febril prolongado y leucocitosis en un adulto joven. Melero M, Lloveras J, Waisman H, Elsner B, Baldessari E. Medicina (Buenos Aires) 1995; 55: 48
Cardiogenic unilateral pulmonary edema: an unreported complication of a digestive endoscopic procedure. Baldessari EM, Mendez-Villarroel A, Maurino E, Nachman FD, Veltri IA. Congest Heart Fail 2009; 15: 252-253
Lifesaving kissing stent for pulmonary trunk stenosis due to primary angiosarcoma. Mendiz O, Lev G, Valdivieso L, Fava C, Gallucci E, Baldessari E, Favaloro R. Ann Vasc Surg 2010; 24: 1135.e9-1135.e12
Tromboembolismo pulmonar submasivo. Baldessari EM, Pavesi A, Mendez Villarroel A, Moukarzel J, Haberman D. Medicina (B Aires). 2010;70:534.
5. Familial osteopoikilosis. Baldessari EM, Mendez-Villarroel A. J Clin Rheumatol. 2011;17:406.
Abdomen agudo doloroso en hipocondrio derecho: UNA CAUSA INUSUAL. Haberman D, Castignola M, Martínez A, Paladín H, Toda M, Baldessari EM, Ramisch D, Gondolesi G. Acta gastroenterol Latinoam 2011; 41: 276, 357-358
Sweet's syndrome. Baldessari EM, Garcia N, Mendez Villarroel A. Intern Med J. 2012;42:103-4
Aspiración de una prótesis dental. Baldessari EM, Ferré-Contreras A, Mendez-Villarroel A. Med Intensiva. 2013;37:60
Guía de recomendaciones para la profilaxis de la enfermedad tromboembólica em adultos em la argentina. Vázquez FJ, Lifschitz E, Watman R, Vilaseca AB, Rodríguez VE, Cruciani AJ, Korin JD, Tabares AH, Ceresetto JM, Clavier Lietti MM, Stinga CA, Bongiorno P, Princz MA, Schutz N, Barada Palmero CE, Salvador R, Canaveri A, Morón J, Pale C, Saimovici J, Capparelli FJ, Wainsztein NA, Baldessari EM, Ariscancela ME. Medicina (B Aires). 2013;73 Suppl 2:1-26.
Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in argentina: a multicentric cross-sectional study. Vazquez F, Watman R, Tabares A, Gumpel C, Baldessari E, Vilaseca AB, Capparelli FJ, Lifschitz E. Thromb J. 2014 Jul 7;12:15 doi:10.1186/1477-9560-12-15
Respiratory failure after treatment of pneumothorax. Baldessari EM, Arceluz MJ, Mendez-Villarroel A. Eur J Intern Med. 2015 May;26(4): e1-2.
Ceguera cortical como manifestación inicial de endocarditis trombótica no bacteriana. Frola A, Baldessari EM, Miusseli Silvester T, Casabe JH. Medicina (Buenos Aires) 2019;79(1):61-63

Publicaciones en libros y programas de educación médica


Supervision cientifica de la traduccion de los siguientes libros de la editorial medica panamericana:”Enfermedades gastrointestinales” Sleisenger / Fordtran 5a edición 1994, ”Medicina Interna –diagnóstico y tratamiento-” Stein 3a edición 1995, ”Medicina ambulatoria” Mengel / Schwiebert edición 1995.
Clinica medica en imagenes. ascitis tabicada. Melero MJ, Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 1996. Primer ciclo, fascículo 2. P. 168-9.
El paciente adulto con plaquetopenia y neutropenia. Baldessari EM, Lamparelli JM, Melero MJ. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 1997. Segundo ciclo, fascículo 3. P. 141-76
Enfermedad de Bechet. Baldessari EM, Melero MJ. En: Medicina. Mautner B. Centro editor de la Fundación Favaloro 1998. P. 1593-94
Enfermedad mixta del tejido conectivo y otros sindromes de superposicion. Baldessari EM, Melero MJ. En: Medicina. Mautner B. Centro editor de la Fundación Favaloro 1998. P. 1575-77
El paciente con dolor toracico. Baldessari EM, Melero MJ. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 1999. Cuarto ciclo, fascículo 4. P. 35-56
Tres niveles de contraste-aire en la seriada gastroduodenal. Melero MJ, Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2000. Quinto ciclo, fascículo 4. P. 176-77
El paciente con ulcera gastroduodenal. Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2001. Sexto ciclo, fascículo 2. p. 37-52
Enfermedad del intersticio pulmonar. Baldessari EM, Melero MJ. En: Correlaciones Clínico-Patológicas. Genaro, Lasala. Akadia 2004. vol 1P. 81-89
Trasplante de médula ósea y enfermedad pulmonar. Baldessari EM, Melero MJ, Mazzei JA, En: Correlaciones Clínico-Patológicas. Genaro, Lasala. Akadia 2004. vol 1P. 347-359
Enfermedad ampollar adquirida. Baldessari EM, Espinola L, Melero M. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2004. Noveno ciclo, fascículo 4. p. 63-83
12. Ensanchamiento del mediastino superior. Baiman A, Aste N, Rosello P, Luduena G, Volpacchio M, Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2006. Undécimo ciclo, fascículo 1. p. 165-172
Neumotórax. Baiman A, Baldessari EM. En: Temas de Terapéutica Médica, 4° edición Tomo 1. Lasala FG. Akadia. 2008 p: 553
Hipotiroidismo. Cano J, Baldessari EM. En: Temas de Terapéutica Médica, 4° edición Tomo 2. Lasala FG. Akadia. 2008 p:947
Nódulo tiroideo. Vera Barros B, Baldessari EM. En: Temas de Terapéutica Médica, 4° edición Tomo 2. Lasala FG. Akadia. 2008 p:941
Infección asociada a catéteres. Baldessari EM. En: Temas de Terapéutica Médica, 4° edición Tomo 2. Lasala FG. Akadia. 2008 p:1417
Síndromes hemorrágiparos. Torres V, Baldessari EM. En: Temas de Terapéutica Médica, 4° edición Tomo 2. Lasala FG. Akadia. 2008 p:1089
SÍNDROME CORONARIO AGUDO CON SUPRADESNIVEL DEL SEGMENTO ST. Hoffmann P, Duronto E, Veltri I, Mendez Villarroel A, Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2011. Decimosexto ciclo, módulo 2. p. 11-43
Enfoque del paciente con fenómeno de raynaud. Veltri I, Barranco C, Mendez Villarroel A, Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2011. Decimosexto ciclo, módulo 2. p. 142-151
Megavejiga y divertículo vesical gigante como causa de matidez desplazable. Baldessari EM, Mendez Villarroel A, Haberman D. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2011. Decimosexto ciclo, módulo 2. p. 172-173
Disnea en un paciente con insuficiencia renal, anemia e hipertensión arterial de difícil manejo. Veltri I, Beretta M, Mendez Villarroel A,Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2011. Decimosexto ciclo, módulo 3. p. 11-29
Disnea progresiva en una mujer de 47 años. Scheridan L, Garcia N, Mendez Villarroel A,Baldessari EM. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2011. Decimosexto ciclo, módulo 4. p. 31-50
Síndrome azúl grisáceo. Baldessari EM, Mendez Villarroel A. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2011. Decimosexto ciclo, módulo 4. p. 121-123
Absceso cerebral por scedosporium apiospermum. Vazquez R, Baldessari EM Mendez Villarroel A. En: Programa de actualización en Medicina Interna (PROAMI) Lasala FG. Editorial médica Panamericana 2011. Decimosexto ciclo, módulo 4. p. 173-175

Actividades Docentes en Departamento de Medicina Oriente U. de Chile

Docencia directa médicos becados en Enfermedades Respiratorias en pasantías por Consultorio Externo del INT
Docencia directa médicos becados en Enfermedades Respiratorias en pasantías por Programa de Tabaquismo del INT, tanto en terapia individual como grupal
Realización de Ciclo de Seminarios sobre Tabaquismo para becados en Enfermedades Respiratorias
Encargado de Reunión Docente del Grupo de Enfermedades Obstructivas (GEO) del INT


PUBLICACIONES DESTACADAS
Libros:

Bello, S. Jara, N. Deja de Fumar !Ahora! Santiago de Chile. Ediciones B, 2006.

Michalland, S. Soto, M. Bello, S. Nalegach, P. Figueroa, J. Vida sin tabaco para ninos, ninas y adolescentes: un desafío urgente. Guía para Educadores. Ministerio de Salud - Ministerio de Educación. 2003.

Bello, S. Soto, M. Salinas, J. Salud Sin Tabaco: Guía Técnico-Metodológica. Programa Ambientes libres del Humo de Tabaco. División de Atención Primaria, Departamento Promoción de la Salud, Programa Ambientes Libres del Humo de Tabaco. Ministerio de Salud. 2001

Bello S., Guerrero C. Para Respirar con Alivio. Manual de Educación sobre Enfermedades Bronquiales Obstructivas del Adulto. Editorial Argé. 1994.-

Capítulos de libros

Bello, S. Consumo de tabaco y estrategias de intervención. pp 141-158. En: Bases, Prioridades y Desafíos de la Promoción de la Salud. Editores: Albala, C. Olivares, S. Salinas, J. Vio, F. Universidad de Chile. Instituto de Nutrición y Tecnología de los Alimentos. 2004

Bello, S. Análisis críticos de los tratamientos para dejar de fumar. pp 243-246. En: Terapéutica Cardiovascular. Actualizaciones. Asenjo, R. Goich, J. Lueg, E. Rodriguez, J.A. Seitz, J. Sociedad Chilena de Cardiología y Cirugía Cardiovascular. Ed. Mediterraneo.1998

Bello S. Transporte de gases. En: Cuidados Intensivos Respiratorios. Munoz F., Caviedes J. eds. Editorial Mediterráneo. 1991.

Revistas Nacionales: últimos 15 años

Bello S, Valdivia G. Guías chilenas de práctica clínica de tratamiento del tabaquismo, 2017. Editorial. Rev Chil Enferm Respir 2017; 33: 163-166

Bello S y Chamorro H. Tratamiento Grupal Intensivo del Tabaquismo. Rev Chil Enferm Respir 2017; 33: 204-205.

Salinas J, Bello S, Chamorro H y Gonzalez CG. Consejería en alimentación, actividad física y tabaco. Instrumento fundamental en la práctica profesional. Rev Chil Nutr 2016; 43 (4): 434-42.

Bello S. Terapia de cesación farmacológica del tabaquismo. Revisión. Bol. Hosp. Vina del Mar 2015, 71 (2): 76-81.

Bello S, Chamorro H, Orellana M. A, Cisternas L y Salinas M. Experiencia de un programa de cesación del tabaquismo en el Instituto Nacional del Tórax. Rev Chil Enf Repir 2015; 31: 94-100.

Bello, S. Chamorro, H. y Barrientos, A. Tratamiento del tabaquismo en pacientes con Enfermedad Pulmonar Obstructiva Crónica. Rev Chil Enf Repir 2013; 29: 24-30

Bello, S. Tratamiento del tabaquismo. Rev Chil Cardiol 2011; 30: 230-239

Bello, S. Flores, A. Bello, M. y Chamorro, H. Diagnóstico y Tratamiento Psico-Social del Tabaquismo. Rev Chil Enf Respir 2009; 25: 218-230

Bello, S Vergara, P O´Ryan, L Alfaro, A y Espinosa A. Estudio de las percepciones y actitudes del personal de una unidad hospitalaria frente a enfermos terminales. Rev Chil Enf Respir 2009; 25: 91-98

Bello, S. Flores, A. Bello M. Tratamiento farmacológico del tabaquismo. Rev Chil Enf Respir 2008, 24:127-137.

Amigo, H. Erazo M. Oyarzún M. Bello S. Peruga A. Tabaquismo y enfermedad pulmonar obstructiva crónica: determinación de fracciones atribuibles. Rev Méd Chile 2006; 134:1275-1282.

Bello S, Michalland S, Soto M, Contreras C y Salinas J. Efectos del humo de tabaco ambiental en no fumadores. Rev Chil Enf Respir 2005; 21:179-192

Bello, S. Michalland, M. Soto, M. Salinas, J. Tabaquismo en funcionarios de educación. Rev Chil Enf Respir 2004; 20: 131-138.

Bello, S. Soto, M. Michalland, S. Salinas, J. Encuesta nacional de tabaquismo en funcionarios de salud. Rev Med Chile 2004; 132: 223-232.

Acuna, M. Bello, S. El Convenio Marco de la OMS para el Control del Tabaco. Rev Chil Enf Respir 2003; 19: 143-145.

PUBLICACIONES DESTACADAS
Barry A, Bottasso OA, Vicco MH. The importance of being scientifically
cautious when criticizing the administration of vaccines: 'retracted' post truth.
Immunotherapy. 2019 Jan;11(1):7-9. doi: 10.2217/imt-2018-0062. PubMed PMID:
30702008.


González FB, Villar SR, Toneatto J, Pacini MF, Márquez J, D'Attilio L,
Bottasso OA, Piwien-Pilipuk G, Pérez AR. Immune response triggered by Trypanosoma
cruzi infection strikes adipose tissue homeostasis altering lipid storage, enzyme
profile and adipokine expression. Med Microbiol Immunol. 2018 Nov 9. doi:
10.1007/s00430-018-0572-z. [Epub ahead of print] PubMed PMID: 30413884.


González F, Villar S, D'Attilio L, Leiva R, Marquez J, Lioi S, Beloscar J,
Bottasso O, Perez AR. Dysregulated Network of Immune, Endocrine and Metabolic
Markers is Associated to More Severe Human Chronic Chagas Cardiomyopathy.
Neuroimmunomodulation. 2018;25(3):119-128. doi: 10.1159/000491699. Epub 2018 Sep
25. PubMed PMID: 30253402.


D'Attilio L, Santucci N, Bongiovanni B, Bay ML, Bottasso O. Tuberculosis, the
Disrupted Immune-Endocrine Response and the Potential Thymic Repercussion As a
Contributing Factor to Disease Physiopathology. Front Endocrinol (Lausanne). 2018
May 1;9:214. doi: 10.3389/fendo.2018.00214. eCollection 2018. Review. PubMed
PMID: 29765355; PubMed Central PMCID: PMC5938357.


D'Attilio L, Díaz A, Fernández RDV, Bongiovanni B, Santucci N, Dídoli G, Lioi
S, Gardenez W, Naninni JL, Del Rey A, Besedovsky H, Bottasso O, Bay ML. The
neuro-endocrine-immune relationship in pulmonary and pleural tuberculosis: a
better local profile in pleural fluid. Int J Tuberc Lung Dis. 2018 Mar
1;22(3):321-327. doi: 10.5588/ijtld.17.0270. PubMed PMID: 29471911.


Díaz A, Bongiovanni B, D'Attilio L, Santucci N, Dídoli G, Fernández RDV,
Kovalevski L, Lioi S, Gardenez W, Brandan N, Nannini LJ, Besedovsky H, Del Rey A,
Bottasso O, Bay ML. The clinical recovery of tuberculosis patients undergoing
specific treatment is associated with changes in the immune and neuroendocrine
responses. Pathog Dis. 2017 Sep 29;75(7). doi: 10.1093/femspd/ftx087. PubMed
PMID: 28854691.


Pérez AR, Lambertucci F, González FB, Roggero EA, Bottasso OA, de Meis J,
Ronco MT, Villar SR. Death of adrenocortical cells during murine acute T. cruzi
infection is not associated with TNF-R1 signaling but mostly with the type II
pathway of Fas-mediated apoptosis. Brain Behav Immun. 2017 Oct;65:284-295. doi:
10.1016/j.bbi.2017.05.017. Epub 2017 Jun 27. PubMed PMID: 28666938.


Spinelli SV, Fernández RDV, Zoff L, Bongiovanni B, Díaz A, D'Attilio L,
Santucci N, Alvarez T, Marchesini MM, Bogue C, Bay ML, Bottasso OA. miR-30c is
specifically repressed in patients with active pulmonary tuberculosis.
Tuberculosis (Edinb). 2017 Jul;105:73-79. doi: 10.1016/j.tube.2017.04.004. Epub
2017 Apr 19. PubMed PMID: 28610790.


Regueira Fernandes A, Romero S, Alcântara de Souza Melo PF, Ramos Araújo PS,
Bottasso O, Rocha A, Brandao E. [Clinical and epidemiological characteristics of
strongyloidiasis in patients with comorbidities]. Rev Chilena Infectol. 2017
Feb;34(1):47-53. doi: 10.4067/S0716-10182017000100007. Review. Spanish. PubMed
PMID: 28394981.


Pavón L, Besedosky H, Bottasso O, Velasco-Velázquez MA, Bauer ME. Clinical
and Experimental Immunomodulation 2016. J Immunol Res. 2017;2017:3152956. doi:
10.1155/2017/3152956. Epub 2017 Jan 16. PubMed PMID: 28191474; PubMed Central
PMCID: PMC5278193.


Fernández R, Díaz A, D'Attilio L, Bongiovanni B, Santucci N, Bertola D,
Besedovsky H, Del Rey A, Bay ML, Bottasso O. An adverse immune-endocrine profile
in patients with tuberculosis and type 2 diabetes. Tuberculosis (Edinb). 2016
Dec;101:95-101. doi: 10.1016/j.tube.2016.09.001. Epub 2016 Sep 12. PubMed PMID:
27865406.


Peverengo L, Prochetto E, Rodeles L, Valenzuela I, Marcipar IS, Bottasso O,
Vicco MH. Antibody profiles induced by Trypanosoma cruzi in chagasic patients
with previous or current exposure to mycobacteria. Pathog Dis. 2016 Dec;74(9).
pii: ftw109. Epub 2016 Nov 3. PubMed PMID: 27815312.


Rodeles LM, Vicco MH, Bontempi IA, Siano A, Tonarelli G, Bottasso OA, Arias
P, Marcipar IS. Combined analysis of cross-reacting antibodies anti-ß1AR and
anti-B13 in advanced stages of Chagas heart disease. Trop Med Int Health. 2016
Dec;21(12):1545-1551. doi: 10.1111/tmi.12791. Epub 2016 Oct 24. PubMed PMID:
27699992.


Vicco MH, Rodeles L, Capovilla GS, Perrig M, Choque AG, Marcipar I, Bottasso
O, Rodriguez C, Cuna W. IgG Autoantibodies Induced by T. cruzi During Pregnancy:
Correlation with Gravidity Complications and Early Outcome Assessment of the
Newborns. Matern Child Health J. 2016 Oct;20(10):2057-64. doi:
10.1007/s10995-016-2035-8. PubMed PMID: 27318490.


González FB, Calmon-Hamaty F, Nô Seara Cordeiro S, Fernández Bussy R,
Spinelli SV, D'Attilio L, Bottasso O, Savino W, Cotta-de-Almeida V, Villar SR,
Pérez AR. Trypanosoma cruzi Experimental Infection Impacts on the Thymic
Regulatory T Cell Compartment. PLoS Negl Trop Dis. 2016 Jan 8;10(1):e0004285.
doi: 10.1371/journal.pntd.0004285. eCollection 2016 Jan. PubMed PMID: 26745276;
PubMed Central PMCID: PMC4706328.


Bini EI, D'Attilio L, Marquina-Castillo B, Mata-Espinosa D, Díaz A,
Marquez-Velasco R, Ramos-Espinosa O, Gamboa-Domínguez A, Bay ML, Hernández-Pando
R, Bottasso O. The implication of pro-inflammatory cytokines in the impaired
production of gonadal androgens by patients with pulmonary tuberculosis.
Tuberculosis (Edinb). 2015 Dec;95(6):701-706. doi: 10.1016/j.tube.2015.06.002.
Epub 2015 Sep 1. PubMed PMID: 26602224.


Hernández-Pando R, Barrios-Payán J, Mata-Espinosa D, Marquina-Castillo B,
Hernández-Ramírez D, Bottasso OA, Bini EI. Correction: The Role of High Mobility
Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary
Tuberculosis. PLoS One. 2015 Aug 27;10(8):e0137263. doi:
10.1371/journal.pone.0137263. eCollection 2015. PubMed PMID: 26313259; PubMed
Central PMCID: PMC4551843.


Hernández-Pando R, Barrios-Payán J, Mata-Espinosa D, Marquina-Castillo B,
Hernández-Ramírez D, Bottasso OA, Bini EI. The Role of High Mobility Group Box 1 
Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis.
PLoS One. 2015 Jul 22;10(7):e0133200. doi: 10.1371/journal.pone.0133200.
eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137263. Botasso, Oscar
Adelmo [corrected to Bottasso, Oscar Adelmo]. PubMed PMID: 26201072; PubMed
Central PMCID: PMC4511675.


Bongiovanni B, Mata-Espinosa D, D'Attilio L, Leon-Contreras JC,
Marquez-Velasco R, Bottasso O, Hernandez-Pando R, Bay ML. Effect of cortisol
and/or DHEA on THP1-derived macrophages infected with Mycobacterium tuberculosis.
Tuberculosis (Edinb). 2015 Sep;95(5):562-9. doi: 10.1016/j.tube.2015.05.011. Epub
2015 May 29. PubMed PMID: 26099547.


Barreto-de-Albuquerque J, Silva-dos-Santos D, Pérez AR, Berbert LR, de
Santana-van-Vliet E, Farias-de-Oliveira DA, Moreira OC, Roggero E, de
Carvalho-Pinto CE, Jurberg J, Cotta-de-Almeida V, Bottasso O, Savino W, de Meis
J. Trypanosoma cruzi Infection through the Oral Route Promotes a Severe Infection
in Mice: New Disease Form from an Old Infection? PLoS Negl Trop Dis. 2015 Jun
19;9(6):e0003849. doi: 10.1371/journal.pntd.0003849. eCollection 2015 Jun. PubMed
PMID: 26090667; PubMed Central PMCID: PMC4474863.


Suarez GV, Vecchione MB, Angerami MT, Sued O, Bruttomesso AC, Bottasso OA,
Quiroga MF. Immunoendocrine interactions during HIV-TB coinfection: implications
for the design of new adjuvant therapies. Biomed Res Int. 2015;2015:461093. doi:
10.1155/2015/461093. Epub 2015 May 14. Review. PubMed PMID: 26075241; PubMed
Central PMCID: PMC4446458.


Pavón L, Bottasso O, Besedosky H, Loria R, Velasco-Velázquez MA. Clinical and
Experimental Immunomodulation 2014. J Immunol Res. 2015;2015:758328. doi:
10.1155/2015/758328. Epub 2015 Apr 28. PubMed PMID: 26060826; PubMed Central
PMCID: PMC4427849.


Suarez GV, Angerami MT, Vecchione MB, Laufer N, Turk G, Ruiz MJ, Mesch V,
Fabre B, Maidana P, Ameri D, Cahn P, Sued O, Salomón H, Bottasso OA, Quiroga MF.
HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while
dehydroepiandrosterone improves cytotoxic antitubercular immune responses. Eur J
Immunol. 2015 Sep;45(9):2529-41. doi: 10.1002/eji.201545545. Epub 2015 Jun 22.
PubMed PMID: 26047476.


Díaz A, Santucci N, Bongiovanni B, D'Attilio L, Massoni C, Lioi S, Radcliffe
S, Dídoli G, Bottasso O, Bay ML. Increased frequency of CD4+ CD25+ FoxP3+ T
regulatory cells in pulmonary tuberculosis patients undergoing specific treatment
and its relationship with their immune-endocrine profile. J Immunol Res.
2015;2015:985302. doi: 10.1155/2015/985302. Epub 2015 Apr 19. PubMed PMID:
25969837; PubMed Central PMCID: PMC4417597.


González FB, Villar SR, Fernández Bussy R, Martin GH, Pérol L, Manarin R,
Spinelli SV, Pilon C, Cohen JL, Bottasso OA, Piaggio E, Pérez AR. Immunoendocrine
dysbalance during uncontrolled T. cruzi infection is associated with the
acquisition of a Th-1-like phenotype by Foxp3(+) T cells. Brain Behav Immun. 2015
Mar;45:219-32. doi: 10.1016/j.bbi.2014.11.016. Epub 2014 Dec 5. PubMed PMID:
25483139.


Lepletier A, de Almeida L, Santos L, da Silva Sampaio L, Paredes B, González
FB, Freire-de-Lima CG, Beloscar J, Bottasso O, Einicker-Lamas M, Pérez AR, Savino
W, Morrot A. Early double-negative thymocyte export in Trypanosoma cruzi
infection is restricted by sphingosine receptors and associated with human chagas
disease. PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3203. doi:
10.1371/journal.pntd.0003203. eCollection 2014 Oct. PubMed PMID: 25330249; PubMed
Central PMCID: PMC4199546.


Santucci N, Díaz A, Bianchi E, Spinelli S, D'Attilio L, Bongiovanni B, Dídoli
G, Brandan N, Nannini L, Bay ML, Bottasso O. Leptin does not enhance
cell-mediated immune responses following mycobacterial antigen stimulation. Int J
Tuberc Lung Dis. 2014 Aug;18(8):981-7. doi: 10.5588/ijtld.13.0780. PubMed PMID:
25199016.


Vicco MH, César LI, Musacchio HM, Bar DO, Marcipar IS, Bottasso OA. Chagas
disease reactivation in a  patient non-Hodgkin's lymphoma. Rev Clin Esp. 2014
Oct;214(7):e83-5. doi: 10.1016/j.rce.2014.04.006. Epub 2014 Jun 2. English,
Spanish. PubMed PMID: 24889774.


Vicco MH, Ferini F, Rodeles L, Cardona P, Bontempi I, Lioi S, Beloscar J,
Nara T, Marcipar I, Bottasso OA. Assessment of cross-reactive host-pathogen
antibodies in patients with different stages of chronic Chagas disease. Rev Esp
Cardiol (Engl Ed). 2013 Oct;66(10):791-6. doi: 10.1016/j.rec.2013.05.028. Epub
2013 Aug 22. PubMed PMID: 24773859.


Bini EI, Mata Espinosa D, Marquina Castillo B, Barrios Payán J, Colucci D,
Cruz AF, Zatarain ZL, Alfonseca E, Pardo MR, Bottasso O, Hernández Pando R. The
influence of sex steroid hormones in the immunopathology of experimental
pulmonary tuberculosis. PLoS One. 2014 Apr 10;9(4):e93831. doi:
10.1371/journal.pone.0093831. eCollection 2014. PubMed PMID: 24722144; PubMed
Central PMCID: PMC3983091.


Vicco MH, Ferini F, Rodeles L, Baretta M, Marcipar I, Bottasso OA. Non-uremic
calciphylaxis and Chagas disease. Rev Clin Esp (Barc). 2014 Jun-Jul;214(5):e55-7.
doi: 10.1016/j.rce.2014.02.013. Epub 2014 Apr 1. PubMed PMID: 24698001.


Pavón L, Besedosky H, Bottasso O, Hernández R, Velasco M, Loria R. Clinical
and experimental immunomodulation. Clin Dev Immunol. 2013;2013:801251. doi:
10.1155/2013/801251. Epub 2013 Dec 19. PubMed PMID: 24454478; PubMed Central
PMCID: PMC3880726.


Vicco MH, Bontempi IA, Rodeles L, Yodice A, Marcipar IS, Bottasso O.
Decreased level of antibodies and cardiac involvement in patients with chronic
Chagas heart disease vaccinated with BCG. Med Microbiol Immunol. 2014
Apr;203(2):133-9. doi: 10.1007/s00430-013-0326-x. Epub 2013 Dec 29. PubMed PMID:
24374613.


Vicco MH, Pujato N, Bontempi I, Rodeles L, Marcipar I, Bottasso OA.
ß1-selective adrenoceptor antagonists increase plasma levels of anti-p2ß
antibodies and decrease cardiac involvement in chronic progressive Chagas heart
disease. Can J Cardiol. 2014 Mar;30(3):332-7. doi: 10.1016/j.cjca.2013.09.017.
Epub 2013 Dec 25. PubMed PMID: 24370375.


D'Attilio L, Díaz A, Santucci N, Bongiovanni B, Gardenez W, Marchesini M,
Bogué C, Dídoli G, Bottasso O, Bay ML. Levels of inflammatory cytokines, adrenal
steroids, and mRNA for GR?, GRß and 11ßHSD1 in TB pleurisy. Tuberculosis (Edinb).
2013 Nov;93(6):635-41. doi: 10.1016/j.tube.2013.07.008. Epub 2013 Aug 7. PubMed
PMID: 23988280.


Villar SR, Ronco MT, Fernández Bussy R, Roggero E, Lepletier A, Manarin R,
Savino W, Pérez AR, Bottasso O. Tumor necrosis factor-? regulates glucocorticoid
synthesis in the adrenal glands of Trypanosoma cruzi acutely-infected mice. the
role of TNF-R1. PLoS One. 2013 May 22;8(5):e63814. doi:
10.1371/journal.pone.0063814. Print 2013. PubMed PMID: 23717489; PubMed Central
PMCID: PMC3661674.


Manarin R, Villar SR, Fernández Bussy R, González FB, Deschutter EV,
Bonantini AP, Roggero E, Pérez AR, Bottasso O. Reciprocal influences between
leptin and glucocorticoids during acute Trypanosoma cruzi infection. Med
Microbiol Immunol. 2013 Oct;202(5):339-52. doi: 10.1007/s00430-013-0294-1. Epub
2013 May 16. PubMed PMID: 23677171.


Nardy AF, Luiz da Silva Filho J, Pérez AR, de Meis J, Farias-de-Oliveira DA,
Penha L, de Araújo Oliveira I, Dias WB, Todeschini AR, Freire-de-Lima CG, Bellio
M, Caruso-Neves C, Pinheiro AA, Takiya CM, Bottasso O, Savino W, Morrot A.
Trans-sialidase from Trypanosoma cruzi enhances the adhesion properties and
fibronectin-driven migration of thymocytes. Microbes Infect. 2013
May;15(5):365-74. doi: 10.1016/j.micinf.2013.02.003. Epub 2013 Feb 24. PubMed
PMID: 23481510.


Angerami M, Suarez G, Pascutti MF, Salomon H, Bottasso O, Quiroga MF.
Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated
dendritic cells by adrenal steroids. Int Immunol. 2013 Jul;25(7):405-11. doi:
10.1093/intimm/dxt004. Epub 2013 Feb 26. PubMed PMID: 23446847.


Sáenz B, Hernandez-Pando R, Fragoso G, Bottasso O, Cárdenas G. The dual face
of central nervous system tuberculosis: a new Janus Bifrons? Tuberculosis
(Edinb). 2013 Mar;93(2):130-5. doi: 10.1016/j.tube.2012.11.011. Epub 2013 Jan 8.
Review. PubMed PMID: 23305698.


Bottasso O, Bay ML, Besedovsky H, Del Rey A. Adverse neuro-immune-endocrine
interactions in patients with active tuberculosis. Mol Cell Neurosci. 2013
Mar;53:77-85. doi: 10.1016/j.mcn.2012.11.002. Epub 2012 Nov 10. PubMed PMID:
23147110.


Spinelli SV, Diaz A, D'Attilio L, Marchesini MM, Bogue C, Bay ML, Bottasso
OA. Altered microRNA expression levels in mononuclear cells of patients with
pulmonary and pleural tuberculosis and their relation with components of the
immune response. Mol Immunol. 2013 Mar;53(3):265-9. doi:
10.1016/j.molimm.2012.08.008. Epub 2012 Sep 8. PubMed PMID: 22964481.


Bongiovanni B, Díaz A, D'Attilio L, Santucci N, Dídoli G, Lioi S, Nannini LJ,
Gardenez W, Bogue C, Besedovsky H, del Rey A, Bottasso O, Bay ML. Changes in the
immune and endocrine responses of patients with pulmonary tuberculosis undergoing
specific treatment. Ann N Y Acad Sci. 2012 Jul;1262:10-5. doi:
10.1111/j.1749-6632.2012.06643.x. PubMed PMID: 22823430.


D'Attilio L, Bozza VV, Santucci N, Bongiovanni B, Dídoli G, Radcliffe S,
Besedovsky H, del Rey A, Bottasso O, Bay ML. TGF-ß neutralization abrogates the
inhibited DHEA production mediated by factors released from M.
tuberculosis-stimulated PBMC. Ann N Y Acad Sci. 2012 Jul;1262:1-9. doi:
10.1111/j.1749-6632.2012.06644.x. PubMed PMID: 22823429.


Tarrés MC, Gayol Mdel C, Picena JC, Alet N, Bottasso O, McIntyre G, Stanford
C, Stanford J. Beneficial effects of immunotherapy with extracts derived from
Actinomycetales on rats with spontaneous obesity and diabetes. Immunotherapy.
2012 May;4(5):487-97. doi: 10.2217/imt.12.37. PubMed PMID: 22642332.


Vicco MH, Bontempi I, Ortiz S, Solari A, Bottasso OA, Marcipar I. Chronic
Chagas disease with cardiodigestive involvement and the TcVI infective form of
Trypanosoma cruzi. A case report. Parasitol Int. 2012 Dec;61(4):735-7. doi:
10.1016/j.parint.2012.04.007. Epub 2012 May 4. PubMed PMID: 22564509.


Pérez AR, Berbert LR, Lepletier A, Revelli S, Bottasso O, Silva-Barbosa SD,
Savino W. TNF-? is involved in the abnormal thymocyte migration during
experimental Trypanosoma cruzi infection and favors the export of immature cells.
PLoS One. 2012;7(3):e34360. doi: 10.1371/journal.pone.0034360. Epub 2012 Mar 26.
PubMed PMID: 22461911; PubMed Central PMCID: PMC3312912.


Quiroga MF, Angerami MT, Santucci N, Ameri D, Francos JL, Wallach J, Sued O,
Cahn P, Salomón H, Bottasso O. Dynamics of adrenal steroids are related to
variations in Th1 and Treg populations during Mycobacterium tuberculosis
infection in HIV positive persons. PLoS One. 2012;7(3):e33061. doi:
10.1371/journal.pone.0033061. Epub 2012 Mar 14. PubMed PMID: 22431997; PubMed
Central PMCID: PMC3303789.


Cárdenas G, Valdez R, Sáenz B, Bottasso O, Fragoso G, Sciutto E, Romano MC,
Fleury A. Impact of Taenia solium neurocysticercosis upon endocrine status and
its relation with immuno-inflammatory parameters. Int J Parasitol. 2012
Feb;42(2):171-6. doi: 10.1016/j.ijpara.2011.11.009. Epub 2011 Dec 26. PubMed
PMID: 22233829.


Santucci N, D'Attilio L, Kovalevski L, Bozza V, Besedovsky H, del Rey A, Bay
ML, Bottasso O. A  multifaceted analysis of immune-endocrine-metabolic alterations
in patients with pulmonary tuberculosis. PLoS One. 2011;6(10):e26363. doi:
10.1371/journal.pone.0026363. Epub 2011 Oct 13. PubMed PMID: 22022605; PubMed
Central PMCID: PMC3192801.

PREMIOS Y OTROS MÉRITOS

Premio por el trabajo Analisis descriptivo de 4776 pacientes internados en los servicios de clinica medica por Covid-19: resultados del registro multicentrico argentino -REMA-COVID-19. Presentado en el XXIX Congreso Nacional de Medicina (SAM) Virtual. Del 29 de noviembre al 3 de diciembre 2021.
Premio por el trabajo “Opinión de Actores Clínicos Relevantes en Argentina Acerca de las Guías ACC/AHA 2017 sobre Manejo de la Hipertensión Arterial” Presentado en el IV Congreso Internacional de Clínica y Medicina Interna IV Congreso Argentino de Clínica Médica y Medicina Interna, XXV Congreso Nacional de Medicina (SAM), 31o Congreso Argentino de Medicina Interna (SMIBA), XLII Jornadas Nacionales de Residencias en Medicina Clínica, IX Jornadas Internacionales de Residentes de Medicina Interna, realizado en la Ciudad Autónoma de Buenos Aires del 7 al 10 de noviembre 2017.
Primera Mención por el trabajo “Arte y Salud: Una Estrategia de Promoción de las Lecturas en Contexto de Internación” Presentado en la XLI Jornadas Médico Científicas del Hospital General de Agudos Enrique Tornú: en la Ciudad Autónoma de Buenos Aires del 2 al 6 de octubre del 2017.
Premio “Mejor Reporte de Caso” al Trabajo “Hipertiroidismo secundario a Coriocarcinoma productor de Gonadotrofina Coriónica Humana en un Varón”. Presentado en el 16o Congreso Internacional de Medicina Interna del Hospital de Clínicas de Buenos Aires. Realizado en la Ciudad Autónoma de buenos Aires del 2 al 5 de agosto del 2016.

ARTÍCULOS EN REVISTAS ARBITRADAS

Resumen de las recomendaciones SAM sobre el manejo de la hipertensión arterial en adultos R. Sabio, P. Valdez, H. Zelechower, J. Pizzorno, L. Cámera, R. Ledesma, H. Milione, R. Parodi, M.E. Barile, D.A. Brosio, L.J. Caliani, H.N. Catalano, A.A. Greca, C. Labaronnie, D. Leff, P.C. Malfante, M.A. Marino, M.M. Ramírez, L.O. Ranzuglia, M.J. Tortolo, G. Uceda, J. Wacker, C. Wisniowski. Revista Argentina de Medicina (RAM) 2018;6(4):207-12 ISSN 2618-4311
Tromboprofilaxis en cirugía: ?Hacemos lo correcto?. Varela G:, Crerar S., Brosio D. et al.. Rev Arg Med 2018;6(2):55-63 ISSN 1515-3460.
El rol del médico clínico en el área quirúrgica en hospitales generales: interconsulta o co-manejo. Varela G:, Crerar S., Brosio D. et al. Revista Argentina de Medicina Vol. 4, Núm. 9 28-34 (2016)
Disnea de Esfuerzo en Paciente sin Antecedentes Neumológicos. Rey D., Brosio D. Revista Argenbtina de Medicina Respiratoria Vol 16 No2 Junio 2016.
Estudio de las Interconsultas Solicitadas por los Servicios Quirúrgicos al Servicio de Medicina Interna. Varela G:, Crerar S., Brosio D. et al. Revista Argentina de Medicina Vol 21 No 4 Dic 2014.
Systemic Lupus Erytematosus. A Reminder about Non-Inflamatory Synovial Effusion during Corticosteroid Treatment. Rillo O., Brosio D., Gusiss S. JCR J. Clin Rheumatol 1997 3 122-3

PUBLICACIONES EN REVISTAS ARBITRADAS

1: Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, Du J, Pedley A, Assaid C, Strizki J, Grobler JA, Shamsuddin HH, Tipping R, Wan H, Paschke A, Butterton JR, Johnson MG, De Anda C; MOVe-OUT Study Group. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16. PMID: 34914868; PMCID: PMC8693688.

2: Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med. 2021 Dec;9(12):1407-1418. doi: 10.1016/S2213-2600(21)00331-3. Epub 2021 Sep 1. Erratum in: Lancet Respir Med. 2021 Oct;9(10):e102. PMID: 34480861; PMCID: PMC8409066.

3: Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group. Once-Daily Plazomicin for Complicated Urinary Tract Infections. N Engl J Med. 2019 Feb 21;380(8):729-740. doi: 10.1056/NEJMoa1801467. PMID: 30786187.

4: Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, Abu-Zidan FM, Ansaloni L, Augustin G, Bala M, Ben-Ishay O, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cortese F, Cui Y, Czepiel J, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckmann C, Eiland EH, Forrester JD, Fraga GP, Frossard JL, Fry DE, Galeiras R, Ghnnam W, Gomes CA, Griffiths EA, Guirao X, Ahmed MH, Herzog T, Kim JI, Iqbal T, Isik A, Itani KMF, Labricciosa FM, Lee YY, Juang P, Karamarkovic A, Kim PK, Kluger Y, Leppaniemi A, Lohsiriwat V, Machain GM, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Ordonez CA, Pagani L, Petrosillo N, Portela F, Rasa K, Rems M, Sakakushev BE, Segovia-Lohse H, Sganga G, Shelat VG, Spigaglia P, Tattevin P, Trana C, Urbánek L, Ulrych J, Viale P, Baiocchi GL, Catena F. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg. 2019 Feb 28;14:8. doi: 10.1186/s13017-019-0228-3. PMID: 30858872; PMCID: PMC6394026.

5: Axfors C, Janiaud P, Schmitt AM, Van't Hooft J, Smith ER, Haber NA, Abayomi A, Abduljalil M, Abdulrahman A, Acosta-Ampudia Y, Aguilar-Guisado M, Al-Beidh F, Alejandria MM, Alfonso RN, Ali M, AlQahtani M, AlZamrooni A, Anaya JM, Ang MAC, Aomar IF, Argumanis LE, Averyanov A, Baklaushev VP, Balionis O, Benfield T, Berry S, Birocco N, Bonifacio LB, Bowen AC, Bown A, Cabello-Gutierrez C, Camacho B, Camacho-Ortiz A, Campbell-Lee S, Cao DH, Cardesa A, Carnate JM, Castillo GJJ, Cavallo R, Chowdhury FR, Chowdhury FUH, Ciccone G, Cingolani A, Climacosa FMM, Compernolle V, Cortez CFN, Costa Neto A, D'Antico S, Daly J, Danielle F, Davis JS, De Rosa FG, Denholm JT, Denkinger CM, Desmecht D, Díaz-Coronado JC, Díaz Ponce-Medrano JA, Donneau AF, Dumagay TE, Dunachie S, Dungog CC, Erinoso O, Escasa IMS, Estcourt LJ, Evans A, Evasan ALM, Fareli CJ, Fernandez-Sanchez V, Galassi C, Gallo JE, Garcia PJ, Garcia PL, Garcia JA, Garigliany M, Garza- Gonzalez E, Gauiran DTV, Gaviria García PA, Giron-Gonzalez JA, Gómez-Almaguer D, Gordon AC, Gothot A, Grass Guaqueta JS, Green C, Grimaldi D, Hammond NE, Harvala H, Heralde FM, Herrick J, Higgins AM, Hills TE, Hines J, Holm K, Hoque A, Hoste E, Ignacio JM, Ivanov AV, Janssen M, Jennings JH, Jha V, King RAN, Kjeldsen- Kragh J, Klenerman P, Kotecha A, Krapp F, Labanca L, Laing E, Landin-Olsson M, Laterre PF, Lim LL, Lim J, Ljungquist O, Llaca-Díaz JM, López-Robles C, López- Cárdenas S, Lopez-Plaza I, Lucero JAC, Lundgren M, Macías J, Maganito SC, Malundo AFG, Manrique RD, Manzini PM, Marcos M, Marquez I, Martínez-Marcos FJ, Mata AM, McArthur CJ, McQuilten ZK, McVerry BJ, Menon DK, Meyfroidt G, Mirasol MAL, Misset B, Molton JS, Mondragon AV, Monsalve DM, Moradi Choghakabodi P, Morpeth SC, Mouncey PR, Moutschen M, Müller-Tidow C, Murphy E, Najdovski T, Nichol AD, Nielsen H, Novak RM, O'Sullivan MVN, Olalla J, Osibogun A, Osikomaiya B, Oyonarte S, Pardo-Oviedo JM, Patel MC, Paterson DL, Pena-Perez CA, Perez- Calatayud AA, Pérez-Alba E, Perkina A, Perry N, Pouladzadeh M, Poyato I, Price DJ, Quero AKH, Rahman MM, Rahman MS, Ramesh M, Ramírez-Santana C, Rasmussen M, Rees MA, Rego E, Roberts JA, Roberts DJ, Rodríguez Y, Rodríguez-Bano J, Rogers BA, Rojas M, Romero A, Rowan KM, Saccona F, Safdarian M, Santos MCM, Sasadeusz J, Scozzari G, Shankar-Hari M, Sharma G, Snelling T, Soto A, Tagayuna PY, Tang A, Tatem G, Teofili L, Tong SYC, Turgeon AF, Veloso JD, Venkatesh B, Ventura- Enriquez Y, Webb SA, Wiese L, Wikén C, Wood EM, Yusubalieva GM, Zacharowski K, Zarychanski R, Khanna N, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG. Association between convalescent plasma treatment and mortality in COVID-19: a  collaborative systematic review and meta-analysis of randomized clinical trials. BMC Infect Dis. 2021 Nov 20;21(1):1170. doi: 10.1186/s12879-021-06829-7. PMID: 34800996; PMCID: PMC8605464.

6: Domecq JP, Lal A, Sheldrick CR, Kumar VK, Boman K, Bolesta S, Bansal V, Harhay MO, Garcia MA, Kaufman M, Danesh V, Cheruku S, Banner-Goodspeed VM, Anderson HL 3rd, Milligan PS, Denson JL, St Hill CA, Dodd KW, Martin GS, Gajic O, Walkey AJ, Kashyap R; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry. Crit Care Med. 2021 Mar 1;49(3):437-448. doi: 10.1097/CCM.0000000000004879. Erratum in: Crit Care Med. 2021 May 1;49(5):e562. PMID: 33555777.

7: Denson JL, Gillet AS, Zu Y, Brown M, Pham T, Yoshida Y, Mauvais-Jarvis F, Douglas IS, Moore M, Tea K, Wetherbie A, Stevens R, Lefante J, Shaffer JG, Armaignac DL, Belden KA, Kaufman M, Heavner SF, Danesh VC, Cheruku SR, St Hill CA, Boman K, Deo N, Bansal V, Kumar VK, Walkey AJ, Kashyap R; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. JAMA Netw Open. 2021 Dec 1;4(12):e2140568. doi: 10.1001/jamanetworkopen.2021.40568. PMID: 34935924; PMCID: PMC8696573.

8: Nuzzolo-Shihadeh L, Camacho-Ortiz A, Villarreal-Salinas D, Barbosa-Quintana A, Pineda-Sic R, Perez-Alba E. Human trichinosis mimicking polymyositis. Int J Infect Dis. 2020 Mar;92:19-20. doi: 10.1016/j.ijid.2019.12.014. Epub 2019 Dec 13. PMID: 31843669.

9: Abreu Y Abreu AT, Velarde-Ruiz Velasco JA, Zavala-Solares MR, Remes-Troche JM, Carmona-Sánchez RI, Aldana-Ledesma JM, Camacho-Ortiz A, Contreras-Omana R, Díaz-Seoane R, Elizondo-Vázquez CT, Garza-González E, Grajales-Figueroa G, Gómez-Escudero O, Jacobo-Karam JS, Morales-Arámbula M, Olivares-Guzmán LO, Sifuentes-Osornio J, Siu-Moguel AG, Soto-Solís R, Valdovinos-García LR, Valdovinos-Díaz MA, Vázquez-Elizondo G, Lazo-de la Vega Jasso SA. Consensus on the prevention, diagnosis, and treatment of Clostridium difficile infection. Rev Gastroenterol Mex (Engl Ed). 2019 Apr-Jun;84(2):204-219. English, Spanish. doi: 10.1016/j.rgmx.2018.12.001. Epub 2019 Apr 12. PMID: 30987771.

10: Aguirre-García GM, Garza-González E, Morfin-Otero R, Camacho-Ortiz A. Clostridioides difficile infections among healthcare workers. Am J Infect Control. 2020 Oct;48(10):1270-1272. doi: 10.1016/j.ajic.2020.01.012. Epub 2020 Feb 28. PMID: 32122672.

Fundador y miembro
Latin America Blood and Marrow Transplantation (LABMT)
Asociacion Peruana de Trasplante de Organos y Tejidos (APTOT)

Miembro internacional de
American Society of Hematology (ASH)
American Society of Blood and Marrow Transplant (ASBMT)
International Society of Cellular Therapy (ISCT)
International Society of Hematology (ISH)
European Hematology Asociation (EHA)
International Society for Advancement of Cytometry (ISAC)

Participante y ponente en más de 100 eventos nacionales e internacionales de la especialidad y autor en 120 publicaciones en el área

PUBLICACIONES DESTACADAS
Las Formas Actuales de la Endocarditis Infecciosa. JH Casabe, LD Suarez y A Torino, Directores. Editorial Panamericana, Buenos Aires, 2000.
Valvulopatías. De la fisiopatología al tratamoiento. JH Casabé, RR Favaloro,JC Final, E Guevara,O Mendiz y A Torino.Ediciones Journal, Buenos aires Marzo 2014.
Fernández A, Quiroga A, Ochoa JP, Mysuta M, Casabé JH, Biagetti M, Guevara E, Favaloro LE, Fava AM, Galizio N. Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model in Hypertrophic Cardiomyopathy in a Reference Center in South America. Am J Cardiol. 2016 Jul 1;118(1):121-6. doi: 10.1016
Barsic B, Dickerman S, Krajinovic V, Pappas P, Altclas J, Carosi G, Casabé JH, Chu VH, Delahaye F, Edathodu J, Fortes CQ, Olaison L, Pangercic A, Patel M, Rudez I, Tamin SS, Vincelj J, Bayer AS, Wang A; International Collaboration on Endocarditis–Prospective Cohort Study Investigators. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis. 2013 Jan;56(2):209-17. doi: 10.1093/cid/cis878. Epub 2012 Oct 16.
Santos JM, Casabe JH, Gabe ED, Vigliano C, Abud J, Guevara E, Favaloro RR, Gurkinfel EP. Clinical finding and follow-up of chronic constrictive pericarditis Medicina (B Aires). 2010;70(4):316-20.
Fernández A, Vigliano CA, Casabé JH, Diez M, Favaloro LE, Guevara E, Favaloro RR, Laguens RP.Comparison of prevalence, clinical course, and pathological findings of left ventricular systolic impairment versus normal systolic function in patients with hypertrophic cardiomyopathy. Am J Cardiol 2011; 108: 545-556.
Tahaniyat Lalani, Christopher H. Cabell, Daniel K. Benjamin, Ovidiu LascaChristoph Naber, Vance G. Fowler, Jr, G. Ralph Corey, Vivian H. Chu, Michael, Fenely, Orathai Pachirat, Ru-San Tan, Richard Watkin, Adina Ionac, Asuncion Moreno, Carlos A. Mestres, José Casabé, Natalia Chipigina, Damon P. Eisen, Denis Spelman, Francois Delahaye, Gail Peterson, Lars Olaison, Andrew Wang and for International Collaboration on Endocarditis_Prospective Cohort Study (ICE-PCS) .Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010;121;1005-1013.

PREMIOS Y OTROS MÉRITOS

2018 y 2019 Distinción a mejor docente escuela de psicología Universidad del Desarrollo (UDD)
2010 Miembro permanente de la Sociedad de Neurología, Psiquiatría y Neurocirugía (SONEPSYN), Chile. Participante estable del grupo de trabajo en Medicina Psico-Somática
2009 Reconocimiento por excelencia en docencia y contribución como profesor visitante. Universidad de California, San Diego (UCSD). U.S.A.
2008 Beca Presidente de la República para estudios de post-grado en el extranjero con el propósito de realizar Fellowship o sub-especialización en trastornos del ánimo y psico-farmacología en la Universidad de California, San Diego (UCSD), U.S.A.

ARTÍCULOS EN REVISTAS ARBITRADAS

1. Correa, R., Rodríguez, N. and Bortolaso, M. What is the nature of the alteration of temporality in Trauma-Related Altered States of Consciousness? A neurophenomenological analysis. European Journal of Trauma and Dissociation 6 (2022)100227.
2. Correa R. Psicofarmacología en la consulta de enlace. Capítulo 3, páginas 42-72. En Psiquiatría de enlace y medicina psicosomática. Calderón J. y González M. editores ,Ed. Mediterráneo, Santiago, Chile, 2016. (Nueva edición en prensa, año 2021)
3. Pulido, Rodrigo Correa, & Malatesta, Rodolfo Philippi. (2019). Optimización versus “Switch” temprano en depresión monopolar: Revisión comprensiva acerca de una controversia clínica. Revista chilena de neuro-psiquiatría, 57(3), 306-313. https://dx.doi.org/10.4067/S0717-92272019000300306
4. Correa, R y Moreira , P. Psiquiatría de enlace en Chile: Breve contexto general, estado actual y perspectivas futuras. Acta Médica Clínica Santa María.2016. Volumen 10 (2):20-24.
5. Correa R. Vincent van Gogh: a pathographic analysis. Med Hypotheses.2014;82(2):141-144.
6. Correa R, Parry B. Women´s mental health clinic: A naturalistic description of the population attended in the San Diego VA Health Care System during a one-year period. J Affect Disord. 2012 Dec 15;142(1-3):31-5.
7. Correa R, Akiskal H, Gilmer W, Nierenberg AA, Trivedi M and Zisook S: Is Unrecognized Bipolar Disorder a Frequent Contributor to Apparent Treatment Resistant Depression? Journal of Affect Disord. 2010 Dec;127(1-3):10-8. Epub 2010 Jul 23.
8. Correa Rodrigo et al.: Neuro-functional and endocrine findings in patients with post-traumatic stress disorder. Alasbimn Journal 11 (44):april 2009. Article N° AJ44-1. http://www.alasbimnjournal.cl/
9. Correa R. “Corporalidad y Conciencia: una mirada desde las neurociencias cognitivas”. Congreso Chileno de Psiquiatría, Noviembre 2009. (Presentación oral como parte del simposium organizado por GDT de medicina psicosomática).
10. Calderón Jorge y Correa Rodrigo. Capítulo: “Trastornos Funcionales de Memoria”: Tratado de Neuropsicología Latinoamericana, Ed. Arcadia, capítulo 24:277-288, 2008.
11. Mena I, Correa P, Nader A, Canessa J, Arteaga M. Trastorno por Estres Post-Traumático. Correlaciones endocrinológicas y neuro-funcionales. LXII Congreso Chileno de Psiquiatría, Noviembre 2007. (presentación oral) www.sonepsyn.cl
12. Mena I, Correa R. and Nader A. Bipolar Disorder complicated by Selfmutilation: neurofunctional changes demonstrated by Tc99mHMPAO NeuroSPECT. Alasbimn Journal 10 (38):octubre 2007. Article N° AJ38-1. http://www.alasbimnjournal.cl/
13. Mena I, Correa R and Nader A. NeuroSPECT and its application in Bipolar Disorder. Nuclear Medicine in Psychiatry. Pages 331-348. Editors A. Otte et. al. Springer Verlag, 2004.
14. Aguilera S, Salas B, Correa R, Sylvester K, Valle C. y Pastene S: Burn-Out en tres unidades médico quirúrgicas de un hospital general. Jornadas nacionales de calidad en salud, Posta Central, Santiago-Chile, 2006 (reporte oral).
15. Mena I, Correa R, Nader A, Boheme V: Bipolar affective disorders: Assessment of functional brain changes by means of Tc99m HMPAO NeuroSPECT.AlasbimnJournal:6(23),January2004.ArticleN°AJ23-2. http://www2.alasbimnjournal.cl/alasbimn/CDA/sec_b/0,1206,SCID%253D6213,00.html
16. Avdaloff W. y Correa R: “Epilepsia y Sueno, Estudio Clínico y Polisomnográfico”. Jornadas Invernales de Epilepsia, Santiago 7 y 8 de Junio de 2002 (reporte tipo póster).

PREMIOS Y OTROS MÉRITOS
1978-1982: Cartas reconocimiento del Director de la Facultad de Medicina y Diploma de reconocimiento de la UNAM por obtener la más alta calificación en todas las materias cursadas (una por cada período lectivo; cuatro en total).
1984: Medalla y Diploma "Gabino Barreda" al mérito universitario por obtener las más altas calificaciones durante la carrera de Medicina, en la Universidad Nacional Autónoma de México.
03/1990: Premio a la "Excelencia en Investigación" otorgado por la American Federation of Clinical Reseach (USA) por el trabajo intitulado: "Renin gene expression in renal ablation" , Reunión anual AFCR, Washington, D.C.
06/1990: Tercer lugar en el Concurso Anual de Investigación básica y clínica de la Universidad de Minnesota con el trabajo intitulado:"Effect of Renal Ablation on the Renin-Angiotensin System Gene Expression"., Junio 1990.
06/1991: Tercer lugar en el Concurso Anual de Investigación básica y clínica de la Universidad de Minnesota con el trabajo intitulado: "Clusterin gene expression in renal ablation", Junio 1991.
1990-1992 Becario en investigación (Research Fellow) de la "Juvenile Diabetes Foundation International" (JDFI) Proyecto: "Renin-Angiotensin Gene Expression Experimental Diabetes Mellitus."
1993 Miembro del Comité Académico en Nefrología de la Universidad Nacional Autónoma de México.
1995 Premio Jaime Woolrich a la Investigación en Nefrología y Urología, otorgado por el Fideicomiso Woolrich, la Secretaría de Salud y el Hospital General con el trabajo intitulado: La Albúmina sérica y la superficie corporal son los mejores predictores del tipo de transporte peritoneal.
1999 Miembro del Comité Científico del Programa del Congreso Americano de Nefrología (ASN, 2002.Miembro del Consejo de la Sociedad Internacional de Nefrología (Council International Society of Nephrology).
2003: Miembro de la Academia Nacional de Medicina, Mexico.
2003 XIV Premio Nacional de Investigación de la Fundación GlaxoSmithKline. Primer Lugar dentro del área de “Investigación Publicada Básica”. Trabajo intitulado: A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132: 2562-2569, 2002.
2003 Premio Reunión Anual de Investigación de la Secretaría de Salud. Acapulco, México. Trabajo intitulado: Trabajo intitulado: A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132: 2562-2569, 2002.
2012: Medalla de Honor de la Sociedad Epañola de Diálisis y Transplante (SEDYT)
2013 Recipiente de la International Distinguished Medal for 2013, otorgada por National Kidney Foundation International
2015: Miembro distinguido de la European Dialysis and transplant association EDTA/ERA.
2019: Medalla Victor Miatelo de la Sociedad Latinoamericana de Nefrología e Hipertensión SC, máximo galardón otorgado por dicha sociedad.

ARTÍCULOS EN REVISTAS ARBITRADAS

1. Correa-Rotter R, Lobato Mendizabal E, Labardini J, Reyes E: Restrictive cardiomiopathy secondary to cardiac amyloidosis as a unique manifestation of multiple myeloma. Rev.Inv.Clin. 39:167-170, 1987
2. Baquera J, Angeles A, Correa-Rotter R, Saldivar S y Pena JC: Nefropatía asociada al síndrome de inmunodeficiencia adquirida (AIDS related nephropathy). Rev.Inv.Clin.(Suppl) 39:105-117, 1987.
3. Correa-Rotter R, Saldivar S, Soto L, Ponce de León S y Pena JC: Recovery of HIV from peritoneal dialysis fluid. Perit.Dial.Int.10:67-69, 1990.
4.Correa-Rotter R, Gamba G, Ochoa C, Onuma L y Pena JC: Glomerulonefritis membranosa: experiencia en el Instituto Nacional de la Nutrición Salvador Zubirán. Rev.Inv.Clin.42: 114-119, 1990.
5. Rosenberg ME, Correa-Rotter R, Inagami T, Kren SM, Hostetter TH: Glomerular renin synthesis and storage in the remnant kidney in the rat. Kidney Int. 40:677-683, 1991.
6. Correa-Rotter R, Hostetter TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int. 41:796-804,1992.
7. Correa-Rotter R, Mariash CN, Rosenberg ME: Loading and transfer control for northern hybridization. Biotechniques. Vol.12:154-158, 1992.
8. Correa-Rotter R, Pérez Castillo A, Chmielewski D, Rosenberg ME: Renin gene expression in the maturing rat kidney. Nephron 62:322-327, 1992.
9.Correa-Rotter R, Hostetter TH, Eddy AA, Rosenberg ME: Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int. 41:938-950, 1992.
10. Correa-Rotter R, Hostetter TH, Rosenberg ME: Effect of dietary protein on renin and angiotensinogen gene expression following renal ablation. Am.J.Physiol. 262:F631-F638, 1992.
11. Smith LJ, Rosenberg ME, Correa-Rotter R, Hostetter TH: The reninangiotensinsystem in chronic renal disease. En: Progression of Rena Disease. Contemporary Issues in Nephrol 26:55-77, 1992.
12. Correa-Rotter R, Hostetter TH, Rosenberg ME: Renal gene expression in renal ablation. Hypertension. 20:483-490, 1992.
13. Correa-Rotter R, Hostetter TH, Nath KA, Rosenberg ME: Interaction of clusterin and complement in renal injury. J Am Soc Nephrol. 3:1172-1179, 1992.
14. Rosenberg ME, Dvrergsten JA, Correa-Rotter R.: Clusterin: An enigmatic protein recruited by diverse stimuli. J. Lab Clin. Med. 121: 205-214, 1993.
15. Correa-Rotter R, Nefropatía diabética: Prevención y tratamiento. Rev. Endocrinol. Nutr. 2: 136-142, 1994.
16. Gamba G., Mejía J.L, Saldivar S., Pena J. C., Correa-Rotter R. Death risk in CAPD patients: The predictive value of the initial clinical and laboratory variables. Nephron 65: 23-7, 1993.
17. Benson M.D., Liepnieks J., Uemichi T., Wheeler G., Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen achain. Nature genetics 3: 252-255, 1993.
18. Correa-Rotter R., Dvergsten J., Nath K.A., Hostetter T.H. Manivel J.C. Rosenberg, M.E. Induction of clusterin in acute and chronic oxidative renal disease and its dissociation from cell injury. Lab. Invest 71: 209, 1994.
19. Cruz C, Juárez-Nicolás F., Tapia E., Correa-Rotter R., Pedraza-Chaverrí J. Abnormalities of coagulation in experimental nephrotic syndrome. Nephron 68: 489-496, 1994.
20. Dvergsten J, Manivel C, Correa-Rotter R., Rosenberg ME. Expression of clusterin in human renal diseases. Kidney Int. 45: 828-835, 1994.
21. Rosenberg M.E., Smith L, Correa-Rotter R, Hostetter T. Paradox of the renin-angiotensin system in chronic disease. Kidney Int. 45: 403-410, 1994.
22. Díaz-Alvarenga A., Abasta-Jiménez M., Gamba G. Bravo B., Correa-Rotter R. Body surface and serum albumin are the strongest predictors of the peritoneal transport type. Adv. Perit Dialysis 10: 47-51, 1994.
23. Cueto Manzano A., Quintanilla L. Correa-Rotter R. Asociación de hepatitis C y glomerulonefritis membranoproliferativa: reporte de 3 casos y revisión de la literatura. Rev. Invest. Clin. 47: 189-196. 1995.
24. Cueto-Manzano A., Gamba G, Abasta M. Correa-Rotter R. Consistency of the Peritoneal Equilibration Test in a Cohort of Nonselected Mexican CAPD patients. Advances in Perit Dial. 11:114-118, 1995.
25. Hernández-Pando R, Pedraza-Chaverrí J, Orozco-Estévez H, Rondán Zárate A, Elinos M, Correa-Rotter R, Larriva-Sahd J. Histological and subcellular distribution of 65 and 70 kD heat shock proteins in experimental nephrotoxic injury. Exp Toxic Pathol 47: 1-7, 1995.
26. Liberman U, Weiss S, et al for The Alendronate Phase III Osteoporosis treatment Study Group. (30 investigadores participantes, incluido Correa-Rotter R, por el INNSZ, México). Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N. Engl. J. Med. 333: 1437-1443, 1995.
27. Cueto-Manzano A, Correa-Rotter R. Biocompatibilidad en Diálisis Peritoneal. Nefrología (España) 16:111-118, 1996.
28. J.P. Devogelaer, H. Broll, R. Correa-Rotter, D. C. Cumming, C. Nagant De Deuxchaisnes, P. Geusens, D. Hosking, P. Jaeger, J.M. Kaufman, M. Leite, J. Leon, U. Liberman, C.J. Menkes, P.J. Meunier, Y. Reid, j. rodriguez, A. Romanowicz, E. Seeman, A. Vermeulen, L.J. Hirsch, A. Lombardi, K. Plezia, A. C. Santora, A. J. Yates and W. Yuan. Oral alendronate induces progressive Incrases in Bone Mass of the Spine, Hip, and Total Body Over 3 Years in Postmenopausal Women With Osteoporosis. Bone Vol. 18 No. 2, 141-150, 1996
29. Espinoza A , Cueto-Manzano A,, Velázquez-Alba Consuelo, Hernández A, Cruz N, Zamora B, Chaparro A, Irigoyen E, Correa-Rotter R. Prevalence of Malnutrition in CAPD diabetic and non-diabetic patients. Advances in Perit Dial. Vol. 12:302-306, 1996.
30. Rojas G, Alberú J, Bordes-Aznar J, Quintanilla L, Lome-Maldonado MC, Cesarman G, Angeles-Angeles A, Correa-Rotter R. Clinical and Pathological Characterization of Postransplantation lymphoproliferatrive disorders in kidney transplant recipients: single institution experiente. Transp Proc. Vol. 28, No. 6: 3317-3320, 1996.
31. Alberú J, Lisker-Melman M, González M, Vargas-Vorackova F, Sixtos S, Ramírez T, De Leo C, Castelán N, Bordes-Aznar J, Correa-Rotter R. Prevalence of hepatitis B and C in patients registered on the cadaver kidney transplant waiting list in Mexico. Transp Proc Vol. 28, No. 6: 3298-3300, 1996.
32. Reyes-Acevedo R, Bezaury-Rivas P, Alberú J, Bordes-Aznar J, Vázquez-Lamadrid J, Rojas G, Gabilondo F y Correa-Rotter R. Posttransplant perirenal collections: clinical significance. Transp Proc. Vol. 28, No. 6: 3312-3313, 1996.
33. M. Gutierrez de la Barrera, R. González, J. Zúniga, G. Rojas, J. Alberú, J. Bordes-Aznar, and R. Correa-Rotter. Acute Abdomen Requiring Emergency Surgery in Renal Allograft Recipients During a Single Center cohort follow-up. Transp Proc. Vol. 28, No. 6: 3333-3334, 1996.
34. Salvador Aburto M., Sebastián Zepeda C., Gilberto ROJAS, Fernando Gabilondo N., Correa-Rotter R., Josefina Alberú G. Infección de vías urinarias en receptores de trasplante renal. Experiencia de 10 años consecutivos en el Instituto Nacional de la Nutrición Salvador Zubirán. Revista Mexicana de Urología Vol. 56, Núm. 6, 236-241, 1996.
35. Cueto-Manzano A, Espinoza A, Hernández A, Correa-Rotter R. Peritoneal transport kinetics do not correlate with nutritional status in CAPD patients. American Journal of Kidney Diseases. Vol. 30, No. 2: 229-236, 1997.
36. Medina-Campos ON, Pedraza-Chaverri J, Correa-Rotter R, Ibarra-Rubio ME. Regulation of hepatic angiotensinogen gene expression in nephrotic rats. Clinical and Experimental Hypertension. Vol. 19, No. 3: 343-362, 1997.
37. Ibarra-Rubio ME, Ramos M, Correa-Rotter R, Pedraza-Chaverri J. Hepatic and extrahepatic angiotensinogen gene expression in rats with acute nephrotic syndrome. Renal Failure, Vol. 19, No. 3:389-399, 1997.
38. Ibarra-Rubio ME, Ramos M, Correa-Rotter R, Pedraza-Chaverri J. Renin, prorenin, and renin gene expression in rats with acute nephrotic syndrome. Clinical and Experimental Pharmacology and Physiology. Vol. 24, 408-414, 1997.
39. Correa-Rotter R, Gerardo Gamba, Biología Molecular en Medicina. VIII. Análisis de la Expresión Génica. Rev. de Invest. Clin, Vol. 49,163-166, 1997.
40. Gabriela Moreno, Alejandra Merino, Adriana Mercado, Juan Pablo Herrera, Correa-Rotter R, Steven C. Hebert & Gerardo Gamba. Electroneutral Na-Coupled Cotransporters Expression In The Kidney During Chronic Variation In Nacl and Water Metabolism. Hypertension, Vol. 31: 1002-1006, 1998.
41. C. Cruz, R. Correa-Rotter, C. Mézquita, O.N. Medina-Campos and J. Pedraza-Chaverrí. Ascites Fluid of Nephrotic Rats: Sodium Dodecyl Sulphate-Polyacrilamide Gel Electrophoresis Protein Pattern and Renin-Angiotensin System. Clinical and Experimental Pharmacology and Physiology Vol. 25: 568-571, 1998.
42. Ricardo Correa-Rotter, Ma. Elena Ibarra-Rubio, Gary Schwochau, Cristino Cruz, John R. Silkensen, Jose Pedraza-Chaverrí, David Chmielewski, Mark E. Rosenberg. Induction of Clusterin in Tubules of Nephrotic Rats. Journal of the American Society of Nephrology, Vol. 9: 33-37, 1998.
43. Alfredo Chew-Wong, Eliana Diná Jiménez, Miguel F. Herrera, Armando Gamboa-Domínguez, Yvonne Richaud-Patin, Paulina Bezzaury, Ricardo Correa-Rotter, Juan A. Rull. Cuatro casos de cáncer de paratiroides. Revista de Investigación Clínica, Vol. 50: 239-244, 1998.
44. Luis González Michaca, Luis Guevara Arnal, Ricardo Correa-Rotter. Ascitis idiopática asociada a hemodiálisis, informe de un caso y revisión de la literatura. Revista de Investigación Clínica, Vol. 51: 49-52, 1999.
45. Kenneth G. Saag, Ronald Emkey, Thomas Schnitzer, Patrice E. Poubelle, Frederico Hawkins, Jonathan D. Adachi, Stefan Goemaere, Gorm Thamsborg, Pierre D. Delmas, Nancy Lane, Ricardo Correa-Rotter, Jose Melo-Gomes, Jose A. Rodriguez-Portales, Melissa Yanover, R. Westhovens, Sol Epstein, Marie-Pierre Malice, Michelle Czachur, Anastasia Daifotis. Alendronate for Use in Patients Receivings Corticosteroids Results of the Combined United States and Multinational Studies. New England Journal of Medicine. Vol. 339(No. 5): 292-299, 1998
46. Jaime Herrera Acosta, Bernardo Rodríguez Iturbe, Ricardo Correa-Rotter, Pablo Massari, Sergio Mezzano, Isidro Salusky, Ita Pfeferman Heilberg, Cesar Agost Carreno, Miguel Saldana Arevalo. Recomendaciones para Programas de Entrenamiento en Nefrología Latinoame ricana. Nef. Latinoamericana, Vol. 4 (No. 4): 218-230, 1997.
47. Francisco Monteón, Ricardo Correa-Rotter, Ramón Paniagua, Dante Amato, Ma. Elena Hurtado, José Luis Medina, Roberto Mario Salcedo, Elvia García, Mario Matos, Julio Kaji, Roberto Vázquez, alfonso Ramos, Ma. Antonieta Schettini, And John Moran. Prevention of Peritonitis with Disconnect Systems in CAPD: A Randomized Control Trial. Kidney International, Vol. 54: 2123-2128, 1998.
48. Alfonso M. Cueto-Manzano, Angel Díaz-Alvarenga and Ricardo Correa-Rotter. Analysis of the Peritoneal Equilibration Test in México and Factors Influencing the Peritoneal Transport Rate. Peritoneal Dialysis International. Vol. 19: 45-50, 1999.
49. Mauricio Sierra, Miguel F. Herrera, Bertha Herrero, Felipe Jiménez, Jesús Sepúlveda, Rosa Gamino, Ofelia González, Ricardo Correa-Rotter. Prospective Biochemical and Scintigraphic Evaluation of Autografted Normal Parathyroid Glands in Patients undergoing Thyroid Operations. Surgery, Vol. 124: 1005-1010, 1998.
50. A. Chew-Wong, J. Alberú, Abasta-Jiménez, E. Alvarez, F. Gabilondo-Navarro, and Ricardo Correa-Rotter. Withdrawal versus continuous cyclosporine therapy in kidney transplant recipients of one haplotype match donors. Transplant Procc. Vol. 31(2B): 1106-1109, 1999.
51. Reina Rosas, Josefina Alberú, Arturo Robles, Ricardo Correa-Rotter, Florencia Vargas-Vorackova, Irma Isordia-Salas, and Abraham Mejluf-Cruz. Serum erythropoietin levels in kidney donors after renal transplantation. Transplantation Vol. 70, N0. 2: 386-387, 2000
52. Luis González-Michaca, Ricardo Correa-Rotter, Gerardo Gamba. Hemodiálisis continua en el tratamiento de la falla renal aguda. Revista de Investigación Clínica. Vol. 52 (No. 1): 31-38, 2000.
53. Alfonso M. Cueto-Manzano and Ricardo Correa-Rotter. Is high peritoneal transport rate an independent risk factor for CAPD mortality. Kidney International, Vol. 57: 314-320, 2000.
54. Steven R. Cummings., Stephen Eckert, Kathryn A. Krueger, Deborah Grady, Trevor J. Powles, Jane A. Cauley, Larry Norton, Thomas Nickelsen, Nina H. Bjarnason, M Morrow, Marc E. Lippman, Dennis Black, J E. Glusman, A Costa, V. Craig Jordan. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women, Results From The MORE Randomized Trial. JAMA. Vol. 281, (No. 23): 2189-2197, 1999.
55. D. Cruz-Robles, R. García-Torres, C. Antignac, L Forestier, S. García de la Puente, R. Correa-Rotter, E. García-López, L. Orozco. Three novel mutations in the COL4A5 gene in Mexican Alport syndrome patients. Clinical Genetics. Vol. 56: 242-243, 1999.
56. Bruce Ettinger, Dennis M. Black, Bruce H. Mitlak, Ronald K. Knickerbocker, Thomas Nickelsen, Harry K. Genant, Claus Christiansen, Pierre D. Delmas, Jose R. Zanchetta, J Strakkestad, Claus C. Gluer, K Krueger, Fredric J. Cohen, Stephen Eckert, Kristine E. Ensrud, Louis V. Avioli, Paul Lips, Steven R. Cummings, for the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene. JAMA. Vol. 282, No. 7: 637 –645, 1999.
57. María de Jesús Ventura, Dante Amato, Ricardo Correa-Rotter and Ramón Paniagua, for the Mexican Nephrology Collaborative Study Group. Relationship between fill volume, intraperitoneal pressure, body size, and subjetive discomfort perception in CAPD patients. Peritoneal Dialysis International. Vol. 20, No. 2, 188–193, 2000.
58. Ramón Paniagua, Dante Amato, Ricardo Correa-Rotter, Alfonso Ramos, Edward F. Vonesh, and Salim K. Mujais, for the Mexican Nephrology Collaborative Study Group. Correlation between peritoneal equilibration test and dialysis adequacy and transport test, for peritoneal transport type characterization. Peritoneal Dialysis International Vol. 20, No. 1, 53-59, 2000.
59. Luis González-Michaca, alfredo Chew-Wong, Liliana Solatero, Gerardo Gamba, Ricardo Correa-Rotter. Biopsia renal percutánea, análisis de 26 años: tasa de complicaciones y factores de riesgo. Rev. Invest. Clin. Vol. 52, No. 2: 125–131, 2000.
60. J. Alberú, Y. Richaud-Patin, E. Mancilla, H. Diliz, R. Correa-Rotter, A. Chew-Wong, N. Uribe, C. de Leo, and L. Llorente. Effect of cyclosporine withdrawall on IL-10 production in kidney transplant recipients. Transplantation Proceedings Vol. 33, 2024-2027, 2001
61. Barry M. Brenner, Mark E Cooper, Dick de Zeeuw, Jean-Pierre Grunfeld, William F Keane, Kiyoshi Kurokawa, Janet B McGill, William E Mitch, Hans Henrik Parving, Guiseppe Remuzzi, Arthur B Ribeiro, Mark D Schuchter, Duane Snavely, Zhongxin Zhang, Roger Simpson, Denise Ramjit, Shahnaz Shahinfar, for the RENAAL Study Investigators. The losartan renal protection study – rationale, study desingn and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the angiotensin II Antagonist Losartan). Journal of the Renin-Angiotensin- Aldosterone System, Vol. 1, No. 4, 328-335, 2000.
62. Jonathan D. Adachi, Kenneth G. Saag, Pierre D. Delmas, Uri A. Liberman, Ronald D. Emkey, Ego Seeman, Nancy E. Lane, Jean-Marc Kaufman, Patrice E. E. Poubelle, Federico Hawkins, Ricardo Correa- Rotter, Charles-Joel Menkes, Jose A. Rodriguez-Portales, Thomas J. Schnitzer, Joel A. Block, Jeffrey Wing, Harris H. McIlwain, Rene Westhovens, Jacques Brown, Jose A. Melo-Gomes, Barry L. Gruber, Melissa J. Yanover, Maria Odette R. Leite, Kerry G. Siminoski, Michael C. Nevitt, John T. Sharp, Marie-Pierre Malice, Thomas Dumortier, Michelle Czachur, Wendy Carofano, and Anastasia Daifotis. Two-Year Effects of Alendronate on Bone Mineral Density and Vertebral Fracture in Patients Receiving Glucocorticoids. A Randomized, Double-Blind, Placebo-Controlled Extension Trial. Arthritis & Rheumatism, Vol. 44, No.1, p.p. 202-211, 2001
63. Cueto-Manzano AM, Gamba G, Correa-Rotter R. Peritoneal protein loss in patients with high peritoneal permeability. Comparison between continuous ambulatory peritoneal dialysis and daytime intermittent peritoneal dialysis. Arch Med Res. Vol. 32(3): 197-201, 2001.
64. Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long–term capd survival and analysis of mortality risk factors: 12–year experience of a single Mexican center. Perit Dial Int, 21(2): 148-153, 2001.
65. Edmund J. Lewis, MD., Lawrence G. Hunsicker, M.D., William R. Clarke, Ph.D., Tomas Berl, M.D., Marc A. Pohl, M.D., Julia B. Lewis, M.D., Eberhard Ritz, M.D., Robert C. Atkins, M.D., Ricahrd Rohde, B.S., and Itamar Raz, M.D., for the collaborative Study Group*. Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. The New England Journal of Medicine. 345(12):851-860, 2001.
66. Brenner, MD., Marck E. Cooper, M.D., Ph.D., Dick de Zeeuw, M.D., Ph.D., William F. Keane, MD.D., William E. Mitch, M.D., Hans-Henrik Parving, M.D., Giuseppe Remuzzi, M.D., Steven M. Snapinn, Ph.D., Zhonxin Zhang, Ph.D., and Shahnaz Shahinfar, M.D., for the RENAAL Study Investigators*. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. The New England Journal of Medicine. 345(12):861-869, 2001.
67. Correa-Rotter R. Nefropatía diabética: ?es posible prevenirla o  retrasar su progresión?. Revista de Investigación Clínica. 53 (6):502- 504, 2001.
68. Ricardo Correa-Rotter. The cost barrier to renal replacement therapy and peritoneal dialysis in the developing world. Peritoneal Dialysis International 21, (Sup. 3): S314-S317, 2001.
69. Ricardo Correa-Rotter, Alfonso Cueto-Manzano. The problem of the high transporter: is survival decreased?. Peritoneal Dialysis International 21, (Sup. 3): S75-S79, 2001.
70. Alfredo Chew-Wong, Liliana Soltero, Eliana Diná, Eduardo Alvarez- Sandoval, Josefina Alberú, Gerardo Gamba, Ricardo Correa-Rotter. Sobrevida del injerto renal en pacientes con lupus eritematoso generalizado. Revista de Investigación Clínica. 54 (1): 21-28, 2002.
71. Carlos A. Aguilar-Salinas, Araceli Díaz-Polanco, Eduardo Quintana, Nayeli Macias, Adriana Arellano, Eika Ramírez, María Luisa Ordónez, Consuelo Velázquez-Alva, Francisco J. Gómez Pérez, Josefina Alberú, and Ricardo Correa-Rotter. Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation. American Journal of Kidney Diseases. 40(1): 169-177, 2002.
72. Armando R. Tovar, Fernanda Munguía, Cristino Cruz, Rogelio Hernández-Pando, Carlos A. Aguilar-Salinas, José Pedraza-Chaverri, Ricardo Correa-Rotter and Nimbre Torres. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132: 2562-2569, 2002.
73. Ramón Paniagua, Dante Amato, Edward Vonesh, Ricardo Correa- Rotter, Alfonso Ramos, John Moran and Salim Mujais. Effects of increased peritoneal clearances on mortality rates in peritoenal dialysis: ADEMEX, a prospective, randomized controlled trial. J. Am. Nephrol 13: 1307-1320, 2002.
74. Jean-Jacques Body, Gregory A. Gaich, Wim H. Scheele, Pandurang M. Kulkarni, Paul D. Miller, Anne Peretz, Robin K. Dore, Ricardo Correa-Rotter, Alexandra Papaioannou, David C. Cumming, and Anthony B. Hodsman. A randomized double-blind trial to compare the efficacy of teriparatide (recombinant human parathyroid hormone (1- 34) with alendronate in postmonopausal women with osteoporosis. J. Clin Endocrinol Metab. 87(10): 4528-4535, 2002.
75. Francisco Aranda-Verástegui, Josefina Alberú, Luis E. Soto-Ramírez, Humberto González-Aguirre, Teresa Munoz Trejo, Eduardo Mancilla, Héctor Díliz, Ricardo Correa-Rotter, Juan Sierra-Madero. Efectividad de la terapia anticipada con ganciclovir en receptores de trasplante reanal de alto riesgo (R-/D+) para desarrollo de enfermedad por citomegalovirus. Revista de Investigación Clínica. 54 (3): 198-203, 2002.
76. Correa-Rotter Ricardo. APD in the Developing World: Is there a  Future. Semin Dial. 15(6):385-387, 2002
77. Luis Eduardo Morales Buenrostro Ricardo Correa-Rotter. Evolución de la Nefrología: de la teoría de los humores a la terapia génica. Revista de Investigación Clínica. 55 (2): 200-206, 2003.
78. J. Hugo Guzmán-Rodríguez, Juan José Plata-Munoz, Eduardo Mancilla, Joel Dorantes, René Narváez, Raúl Martínez, Manuel Tielve, Paulina Bezaury, Ricardo Correa-Rotter, Josefina Alberú. Estenosis arterial renal posterior a trasplante: tratamiento con angioplastia transluminal percutánea y colocación de endoprótesis luminal metálica expandible. Revista de Investigación Clínica. 55 (3):297-304, 2003.
79. Lisker R, Lopez MA, Jasqui S, Ponce De León Rosales S, Correa- Rotter R, Sanchez S, Muchinick OM. Association of vitamin D receptor polymorphisms with osteoporosis in mexican postmenopausal women. Hum Biol Vol 75 (3): 399-403, 2003.
80. McCarthy JT, Moran J, Posen G, Neypoldt JK, Hull AR, Jaber BL, Correa-Rotter R. A time for rediscovery: chronic hrmofiltration for end-stage renal disease. Semin Dial. 16(3):199-207, 2003.
81. Isaac Echeverría-Valenzuela, Gustavo Us-De-Paz, Rafael Fajardo- Cevallos, Ricardo Correa-Rotter, Francisco J. Gómez Pérez, Miguel F. Herrera. Síndrome de conn: una experiencia quirúrgica. Revista de Investigación Clínica. 55 (5): 484-488, 2003.
82. Ernesto Sabath, Olynka Vega, Ricardo Correa-Rotter. Referencia temprana al nefrólogo: impacto sobre la hospitalización inicial y los seis primeros meses en diálisis peritoneal continua ambulatoria. Revista de Investigación Clínica. 55 (5): 489-493, 2003.
83. Josefina Alberú, Yvonne Richaud-Patin, Luis Gabriel Vázquez- Lavista, Claudia de Leo, Hugo Guzmán-Rodríguez, Eduardo Mancilla, Ricardo Correa-Rotter, Alfredo Chew-Wong, and Luis Llorente. In vivo IL-10 and TGF-b production by PBMC from long-term kidney transplant recipients with excellent graft function: a possible feedback mechanism participating in immunological stability. Clinical Transplantation. 18:1-5, 2004.
84. José Pedraza-Chaverrí, Diana Barrera, Rogelio Hernández-Pando, Omar N. Medicna-Campos, Cristino Cruz, Fernanda Munguía, César Juárez-Nicolás, Ricardo Correa-Rotter, Nimbe Torres, Armando R. Tovar. Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sciences 74: 987-999, 2004.
85. Paul Lips, Tu Duong, Ann Oleksik, Dennis Black, Steven Cummings, David Cox, and Thomas Nichelsen for the Multiple Outcomes of Raloxifene Evaluation Study Grou. A Global Study of Vitamin D Status and Parathyroid Functional in Postmenopausal Women With Osteoporosis: Baseline Data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. Vol. 86 Num. 3, 1212-1221, 2004
86. Henry G. Bone, David Hosking, Jean-Pierre Devogelaer, Joseph R. Tucci, Ronald E. Emkey, Richard P. Tonino, José Adolfo Rodriguez- Portales, Robert W. Downs, Jayanti Gupta, Arthur C. Santora, y Uri A. Liberman. Por el Grupo de Estudio Fase III de Tratamiento de la Osteoporosis con Alendronato. Ten years experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350: 1189- 1199, 2004.
87. L.E. Morales-Buenrostro, L. Llorente, Y. Richaud-Patin, C. De Leo, E. Soto-Vega, A. Díaz-Alderete, L.G. Vázquez-Lavista, S. Coto, R. Correa- Rotter, and J. Alberú. Effect of Rapamycin on Cytokine Profile in Kidney Transplant Recipients Treated –with Triple drug TherapyTransplantation Proceedings 36, 1661-1663, 2004.
88. R. Correa-Rotter, Sarala Naicker, Ivor J. Katz, Sanjay K. Agarwal, Raul Herrera Valdes, Dan Kaseje, Bernardo Rodriguez-Iturbe, Faissal Shaheen, and Chitr Sitthi-Amorn, on Behalf or the ISN-COMGAN BELLAGIO STUDY GROUP 2004. Demographic and epidemiologic transition in the developing world: Role of albuminuria in the early diagnosis and prevention of renaol and cardiovascular disease. Kidney International, Vol. 66, sup. 92:S1-S6, 2004.
89. Nahum Méndez-Sánchez, Daniel Motola-Kuba, Norberto C. Chavez- Tapia, Jesús Bahena, Ricardo Correa-Rotter, and Misael Uribe. Prevalence of Hepatitis C Virus Infection among Hemodialysis Patients at Tertiary-Care Hospital in Mexico City, Mexico. Journal of Clinical Microbiology, Sept. 2004, 4321-4322, Vol. 42, No. 9, 2004.
90. Monique Arlot, Pierre J. Meunier, Georges Boivin, Lilliam Haddock, Juan Tamayo, Ricardo Correa-Rotter, Salomón Jasqui, David W Donley, Gail P Dalsky, Javier San Martin, and Erik Fink Eriksen. Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters. Journal of Bone and Mineral Research, Vol. 20, Num (7):1244-1253, 2005.
91. Alfonso M. Cueto-Manzano, Luis E. Morales–Buenrostro, Liliana González-Espinoza, Norma González-Tableros, Fabiola Martín-del- Campo, Ricardo Correa-Rotter, Isela Valera, and Josefina Alberú. Markers of Inflammation Before and After Renal Trasnplantation. Transplantation, Vol. 79, Number 12, 2005.
92. Juan Vicente Cuellar-Gonzalez, Ricardo Correa-Rotter. Evaluación del receptor de trasplante renal, Renal transplant`s recipient evaluation. Revista de Investigación Clínica, Vol. 57, Num. 2, 187-194, 2005.
93. Ricardo Correa-Rotter, Luis González-Michaca. Early detection and prevention of diabetic neprhopathy: A challenge calling for mandatory action for Mexico and the developing world. Kidney International. Vol. 68, Suppl. 98, S69-S75, 2005.
94. Dirks JH, de Zeeuw D, Agarwall SK, Atkins RC, Correa-Rotter R, D Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje D, Katz IJ, Naicker S, Rrodriguez-Iturbe B, Schieppati A, Shaheen F, Sitthi-Amorn C, Solez K, Viberti G, Remuzzi G, Weening JJ: Prevention of chronic kidney and vascular disease: Toward global health equity - the Bellagio 2004 Declaration. Kidney International. Vol. 68(s98): S1-S6, 2005.
95. Alfredo Chew-Wong, Josefina Alberú- Gómez, Marcela Abasta- Jiménez, Francisco Márquez-Díaz y Ricardo Correa-Rotter. Hipertensión arterial postrasplante renal: factores de riesgo asociados e influencia en la supervivencia del injerto renal. Gaceta Médica de México, Vol. 141, No. 6, Pag. 461-467, 2005.
96. Edy Henández-Hernández, Josefina Alberú, Luis González-Michaca, Miriam Bobadilla-del Valle, Ricardo Correa-Rotter and José Sifuentes- Osornio. Screening for Tuberculosis in the Study of the Living Renal Donor in a Developing Country. Transplantation. Vol 81, 290 – 292, 2006.
97. Dirks JH, Robinson S. Burdmann E, Ricardo Correa-Rotter, Mezzano S. Rodriguez-Iturbe B. Prevention stratefies for chronic kidney disease in Latin America: a strategy for the nest decade –a report on the Villarica Conference. Ren Fail 28(8): 611-615, 2006.
98. John Moran and Ricardo Correa-Rotter. Revisiting the Peritoneal Dialysis Dose. Seminars in Dialysis. Vol 19, No. 2: 102 – 104, 2006
99. John H Dirks, Sheila Robinson, Emmanuel Burdmann, Ricardo Correa-Rotter, Sergio Mezzano and bernardo Rodríguez-Iturbe. Prevention strategies for chronic disease in Latin American. Nature Clinical Practice Nephrology, Vol 2. No. 7, 347, 2006
100. María de los Angeles Espinosa-Cuevas, Lucía Rivas-Rodríguez, Enna Cristal González-Medina, Ximena Atilano-Carsi, Paola Miranda – Alatriste, Ricardo Correa-Rotter. Vectores de impedancia bioelectrica para la composición corporal en población mexicana. Revista de Investigación Clínica, Vol. 59, Núm. 1, 15-24, 2007.
101. Ricardo Correa-Rotter. Renal Replacement Therapy in the Developing World: Are We on the Right Track, or Should There be a  New Paradigm? J. Am Soc Nephrol, 18: 1635-1636, 2007
102. Patricia Volkow, Juan W Zinser and Ricardo Correa-Rotter. Moleculaty targeted therapy for kaposi´s sarcoma in a kidney transplant patient: case report, “what worked and what did not”. BMC Nephrology. 2007, 8:6
103. Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drueke, Jürgen Floege, William G. Goodman, Gerard M. London, Kenneth W. Mahaffey, Sharon M. Moe, David C. Wheeler, Moetaz Albizem, Kurt Olson, Preston Klassen, and Patrick Parfrey. Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and Design overview. American Society of Nephrology. Vol. 2 Num. 5: 898-905, 2007.
104. Cristino Cruz, Ricardo Correa-Rotter, Dolores Javier Sánchez- González, Rogelio Hernández-Pando, Perla D. Maldonado, Claudia María Martínez-Martínez, Omar Noel Medina-Campos, Edilia Tapía, Diana aguilar, Yolanda I. Chirino nad José Pedraza-Chaverrí. Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats. Am. J. Physiol Renal Physiol 293: F1691- F1698, 2007
105. Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W. Klinger M, Rutkowski B, Ricardo Correa-Rotter, Dougherty FC, BA16528 Study Investigators. The continuous erithropoietin receptor activator (C.E.R.A) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study. Clin Nephrol 67:5 306-317, 2007.
106. Javier Zúniga-Varga, Pablo Francisco Belaunzarán-Zamudio, Josefina Alberú, Ricardo Correa-Rotter.,Citomegalovirus y Trasplante Renal: Un Reto Diagnostico y Terapeutico. Nefrología Latinoamericana, Vol. 12, No. 1, agosto 2007.
107. Ricardo Correa-Rotter., Ana María Cusumano. Present, Prevention, and Management of Chronic Kidney Disease in Latina America. Blood Purif . Vol. 26, 90-94, 2008.
108. Ramón Paniagua, Dante Amato, Salim Mujais, Edward Wonesth, Alfonso Ramos, Ricardo Correa-Rotter, Walter H Horld. Predictive Value of Brain Natriuretic Peptides in Patients on Peritoneal dialysis: Results from the ADEMEX Trial. Clinical Journal of the American Society of Nephrology. Vol. 3, No. 2, 407-415, 2008.
109. Olynka Vega, Guillermo Cárdenas, Ricardo Correa-Rotter, Josefina Alberú, Luis E. Morales-Buenrostro. Basiliximab vs limited-dose daclizumab (2 mg/kg) administered in single or two separated doses in kidney transplantation. Revista de Investigación Clínica, Vol. 60, Num 2, 82-86, 2008.
110. Ernesto López-Almaraz, Ricardo Correa-Rotter, Dialysis disequilibrium syndrome and other treatment complications of extreme uremia: A rare ocurrence tet not vanished. International Society for Hemodialyisis International Vol. 12, 301-306, 2008.
111. Josefina Alberú, Luis E. Morales –Buenrostro, Ricardo CorreaRotter, Teresa Munoz-Trejo, Javie Zúniga Varga, Juan V. Cuellar- González, Héctor Mayorga-Madrigal, Ramón Vanegas-Carrero, Francisco Aranda, Roxana Rodríguez-Romo, Carlos Herrera-García, Luis González-Michaca, Juan G. Sierra-Madero. Long-term renal grafo function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy. Revista de Investigación Clínica. Vo. 60, Núm 5, 365-374, 2008.
112. Edgar Dehesa-López, Rosario Angélica Pérez-Gutiérrez, Rafael Valdez-Ortiz, Luis E. Morales-Buenrostro, Ricardo Correa-Rotter. Factores clínicos y de laboratorio relacionados con progresión a  enfermedad renal crónica en pacientes con enfermedad renal poliquística autosómica dominante. Revista de Investigación Clínica. Vo. 61, Núm 5, 364-370, 2009.
113. A. Cataneo-Dávila, J. Zúniga-Varga, Ricardo Correa-Rotter, and J. Alberú. Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen With CNI Reduction of Elimination. Transplantation Proceedings. 41: 4138- 4146, 2009.
114. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009 Nov 19;361(21):2019-32. Epub 2009 Oct 30.
115. R. Sorto, S.S. Irizar, G. Delgadillo, J. Alberú, Ricardo Correa-Rotter, and L.E. Morales-Buenrostro. Risk Factors for Urinary Tract Infections During the First Year After Kidney Transplantation. Transplantation Proceedings, 42, 280-281, 2010
116. Espinosa Cuevas, G. Navarrete Rodríguez, ME. Villena Martinez, X. Atilano Carsi, P. Miranda Alatriste, T. Tostado Gutiérrez, and Ricardo Correa-Rotter. Body fluid volume and nutritiona status in hemodiálisis: vector bioelectric impedance análisis. Clinical Nephrology, Vol. 73 No.4, 300-308, 2010.
117. Bernardo Rodriguez-Iturbe, and Ricardo Correa-Rotter. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease. Expert Opin Pharmacother. ISSN 1465-6566. 2010
118. A lan L. Burshell, Rudiger Moricke, Ricardo Correa-Rotter, Peiqi Chem, Margaret R. Warner, Gail P. Dalsky, Kathleen A. Taylor, John H. Krege. Changes in Biomarkers Predict Response to Teriparatide or Alendronate in patients with Glucocorticoid-induced Osteroporosis. Bone. Apr;46(4):935-939. 2010
119. Olynka Vega, angélica Pérez-Gutiérrez, Sergio HernándezÓrdonez, Ricardo Correa-Rotter, Josefina Alberú, Luis E. Morales- Buenrostro, ¿Es necesario un inhibidor de calcineurina como parte del esquema de injunosupresión en receptores de trasplante renal que comparten dos haplotipos con su donador?. Revista de Investigación Clínica. Vol. 62, Núm 3, 200-205, 2010.
120. M. Arvizu-Hernández, L.E. Morales-Buenrostro, M. Vilatoba- Chapa, E. Mancilla-Urrea, N. Uribe-Uribe, M.C. Avila-Casado, C. de Leo, A. Arvizu, J.L. Gonzalez, J. Torres. B. Gabilondo, Ricardo Correa-Rotter and J. Alberú, Time of Occurrence of Kidney Acute Antibody-Mediated Allograft Rejection/Acute Cellular Rejection and Cell Senescente: Implications for Function Outcome. Transplantation Proceedings, 42, 2486-2492, 2010.
121. R. Vanholder, D. Borniche, S. Claus, Ricardo Correa-Rotter, R. Crestani, M.C. Ferir, N.Gibney, A. Hurtado, V.A. Luyckx, D. Portilla, S. Rodriguez, M.S. Sever, J. Vanmassenhove, R. Wainstein. When the Earth trembles in the Americas: The Experience of Haiti and Chile 2010. Nephron Clin Pract 117, c184-c197, 2011
122. Valdez Ortiz R., José Sifuentes-Osornio., Morales-Buenrostro LE., Ayala-Palma H., Dehesa-López E., Alberú J., Ricardo Correa-Rotter. Risk factors for infections requiring hospitalization in renal transplant recipien ts: a cohort study, Int Journal of Infectious Diseases, (15) e188-e196, 2011.
123. Tovar-Palacio C., Tovar AR., Torres N.M, Cruz C., Hernández- Pando R., Salas-Garrido G., Pedraza-Chaverri J., Ricardo Correa-Rotter. Proinflammatory gene expresión and renal lipogenesis are modulated by dietary protein content in obese Zucker fa/fa rats. Am J Physiol Renal Physiol. 300 (1), F263-271, 2011.
124. D. Cuevas-Ramos, P. Almeda-Váldes, M. Arvizu, J. Mata, L.E. Morales-Buenrostro, B. Gabilondo, M. Vilatobá, Ricardo Correa-Rotter, F.Gabilondo-Navarro, R. Mehta, C.A. Aguilar-Salinas, J. Alberú, and F.J. Gómez-Pérez. Association of the Metabolic Síndrome and Long-Term Renal Function in Kidney Donors. Transplantation Proceedings, 43, 1601-1606, 2011.
125. Abel Torres Munoz, Rafael Valdez-Ortiz, Carlos González-Parra, Elvy Espinoza-Dávila, Luis E. Morales-Buenrostro, Ricardo Correa- Rotter, Percutaneous renal biopsy of native kidneys: efficiency, safety and risk factors associated with major complications. Arch. Med. Sci 2011
126. Marcelo Orías and Ricardo Correa-Rotter, Chronotherapy in Hipertensión: A Pill at Night Makes Things Right?. J. Am Soc Nephrol, 22: 2139-2155, 2011
127. N. Campbell, Ricardo Correa-Rotter, B. Neal, F.P. Cappuccio. New evidence relating to the health impact of reucing salt intake. Nutrition, Nmetabolism & cardiovascular Diseases, 21, 617-619, 2011. 127. Olynka Vega-Vega, Ricardo Correa-Rotter. La enfermedad de Fabry-anderson: estado actual del conocimiento. Revista de Investigación Clínica, 63(3), 314-32|, 2011.
128. Glenn M, Chertow, Ricardo Correa-Rotter, Geoffrey A, Block, Tilman B, Drueke, Jürgen Floege, William G. Goodma, Charles A, Herzog, Yumi Kubo, Gerard M. London, Kenneth W, Mahaffey Thomas- Christian Mix, Sharon M. Moe, David C. Wheeler and Patrick S. Parfrey. Baseline characteristics of subjects enrolled in the Evaluation of cinacalcet HCI Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant. 27 2872-2879, 2012
129. Elba Onelida Medina-Hernández, Benjamin Antonio Rodríguez- Espino, Ana María Hernández-Sánchez, Lourdes Matilde Ortiz- Vázquez, Perla Oropeza, Daniel Diaz, Rubén Aldana-Vergara, Francisco Velásquez-Forero, Olynka Vega, Ricardo Correa-Rotter, Mara Medeiros-Domingo. Prevalencia de polimorfismos del receptor de vitamina D en pacientes pediátricos mexicanos con enfermedad renal crónica. Bol Med Hosp. Infant Mex 69(2): 104-110, 2012
130. Kleyton Bastos, Luis Antonio Lucarelli, Elizabeth De Francesco.Daher, Roberto Pecoits Filho, Carlo Henríquez, Beatriz Espinoza, Ignacio Villanueva, Emma Schwedt, Ruben Schiavelli, Ricardo Correa-Rotter, C.E.R.A maintains stable hemoglobin in Latin American Patients on dialysis. Int Urol Nephrol. PAGINAS 2012.
131. Chertow GM, Block GA, Ricardo Correa-Rotter, Drüeke TB, Floege J, R, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. EVOLVE Trial Investigators Effect of cinacalcet on cardiovascular disease in patients undergoin dialysis. N Engl J Med. Dec 27;367(26):2482-94. 2012
132. Campbell NR, Ricardo Correa-Rotter,, Legowski B, Legetic B. Efforts to reduce dietary salt in the Americas, Rev Panam Salud Publica. Oct;32(4):253-257. 2012
133. Gansevoort RT, Ricardo Correa-Rotter, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. (13) 60595-4 May 30. 2013
134. Bautista E, Arcos M, Jimenez-Alvarez L, García-Sancho MC, Vázquez ME, Pena E, Higuera A, Ramírez G, Fernández-Plata R, Cruz- Lagunas A, García-Moreno SA, Urrea F, Ramírez R, Ricardo Correa- Rotter, Pérez-Padilla JR, Zúniga J. Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection. Exp Mol Pathol. Jun; 94(3):486- 92. 2013.
135. Helena Zaldívar-Alcántara, luis Enrique Herrera Jiménez, Edgar Dehaesa-López, Ricardo Correa-Rotter. Factores de riesgo para el desarrollo de complicaciones trombóticas en pacientes con lupus eritematosos sistémico y nefropatía lúpica. Revista de Investigación Clínica,l Vol. 65, Núm. 3 pp 199-208, 2013.
136. Progress with a global branded food composition database. Food Monitoring Group. Food Chem. 2013 Oct 1;140(3):451-7.
137. Wladyslaw Sulowicz, Francesco Locatelli, Jean-Philippe Rychelynck, Jozsef Balla, Botond Csiky, Kevin Harris, Patricia Ehrhard, and Ulrich Beyer, Ricardo Correa-Rotter, of the PROTOS Study Investigators. Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly. Int. Urol Nephrol 45(5):1355-1364, 2013
138. Bellorin-Font E, Ambrosoni P, Carlini RG, Carvalho AB, Ricardo Correa-Rotter, Cueto-Manzano A, Jara A, Jorgetti V, Negri AL, Olaizola I, Salusky I, Slatopolsky E, Weisinger JR; Comité de Metabolismo Mineral y Óseo; Sociedad Latinoamericana de Nefrología e Hipertensión (SLANH). Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults. Nefrologia. 33 Suppl 1:1- 28. 2013.
139. de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ- Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators. Bardoxolone methyl in type 2 diabetes and stage 4  chronic kidney disease. N Engl J Med. Dec 26;369(26):2492-503
140. Parfrey PS, Chertow GM, Block GA, Ricardo Correa-Rotter, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Dehmel B, Trotman ML, Modafferi DM, Goodman WG. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab. Dec;98(12):4834-44, 2013
141. Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA, Cicerchi C, Inaba S, Le M, Miyazaki M, Glaser J, Ricardo Correa-Rotter, González MA, Aragón A, Wesseling C, Sánchez-Lozada LG, Johnson RJ. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int. Dec 11 2013.
142. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of Unknown Origin in Central America: The Case for a Mesoamerican Nephropathy. Am J Kidney Dis. Mar;63(3):506-520, 2014
143. Carlini R, Obrador G, Campistrús N, Andrade L, Chifflet L, Bregman R, Locatelli A, Correa-Rotter R, Poblete H. The first report of The Latin American Society of Nephrology and Hypertension (SLANH) Anemia Committee in chronic hemodialysis patients. Nefrologia. 34(1):96-104, 2014
144. Ramírez-Sandoval JC, Barrera-Chimal J, Simancas PE, Rojas- Montano A, Correa-Rotter R, Bobadilla NA, Morales-Buenrostro LE. Urinary neutrophil gelatinase-associated lipocalin predicts graft loss after acute kidney injury in kidney transplant. Biomarkers. Feb;19(1):63-9, 2014
145. Ramos-Kuri M, Olvera D, Morales JJ, Rodriguez-Espino BA, Lara-Mejía A, De Los Ríos D, Obrador GT, Granados J, Correa- Rotter R, Clinical, Histological and Molecular Characteristics of Mexican Patients with Fabry Disease and Significant Renal Involvement. Arch Med Res. 2014 Apr;45(3):257-62
146. Valdez-Ortiz R, Bestard O, Llaudó I, Franquesa M, Cerezo G, Torras J, Herrero-Fresneda I, Correa-Rotter R, Grinyó JM. Induction of suppressive allogeneic regulatory T-cells via rabbit- ATG during homeostatic proliferation in rat kidney transplantation. Transpl Int. 2014 Sep 10. doi: 10.1111/tri.12448.
147. Arreola-Guerra JM, Rincón-Pedrero R, Cruz-Rivera C, Belmont- Pérez T, Correa-Rotter R, Nino-Cruz JA. Performance of MDRDIDMS and CKD-EPI equations in Mexican individuals with normal renal function. Nefrologia. 2014 Sep 26;34(5):591-598.
148. In reply to 'Pesticides and the epidemic of CKD in Central America'. Correa-Rotter R, Wesseling C, Johnson RJ. Am J Kidney Dis. 2014 Sep;64(3):477-8.
149. Campbell NR, Appel LJ, Cappuccio FP, Correa-Rotter R, Hankey GJ, Lackland DT, MacGregor G, Neal B, Niebylski ML, Webster J, Willis KJ, Woodward M. A call for quality research on salt intake and health: from the World Hypertension League and supporting organizations. J Clin Hypertens (Greenwich). 2014 Jul;16(7):469-71.
150. Johnson RJ, Rodriguez-Iturbe B, Roncal-Jimenez C, Lanaspa MA, Ishimoto T, Nakagawa T, Correa-Rotter R, Wesseling C, Bankir L, Sanchez-Lozada LG. Hyperosmolarity drives hypertension and CKD-- water and salt revisited. Nat Rev Nephrol. 2014 Jul;10(7):415-20.
151. Lombardi R, Rosa-Diez G, Ferreiro A, Greloni G, Yu L, Younes- Ibrahim M, Burdmann EA; Acute Kidney Injury Committee of the Latin American Society of Nephrology and Hypertension Working Group.Acute kidney injury in Latin America: a view on renal replacement therapy resources. Nephrol Dial Transplant. 2014 Jul;29(7):1369-76.
152. de Zeeuw D, Coll B, Andress D, Brennan JJ, Tang H, Houser M, Correa-Rotter R, Kohan D, Lambers Heerspink HJ, Makino H, Perkovic V, Pritchett Y, Remuzzi G, Tobe SW, Toto R, Viberti G, Parving HH. The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy. J Am Soc Nephrol. 2014 May;25(5):1083-93.
153. Ramirez-Sandoval JC, Barrera-Chimal J, Simancas PE, Correa- Rotter R, Bobadilla NA, Morales-Buenrostro LE. Tubular urinary biomarkers do not identify aetiology of acute kidney injury in kidney transplant recipients. Nephrology (Carlton). 2014 Jun;19(6):352-8.
154. Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, CorreaRotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Dehmel B, Goodman WG, Drüeke TB; for the EVOLVE Trial Investigators. Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. J Am Soc Nephrol. 2014 Dec 11. pii: ASN.2014040414.
155. Campbell NR, Correa-Rotter R, Cappuccio FP, Webster J, Lackland DT, Neal B, MacGregor GA. Proposed Nomenclature for Salt Intake and for Reductions in Dietary Salt. J Clin Hypertens (Greenwich). 2014 Nov 21. doi: 10.1111/jch.12442.
156. Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman ML, Abdalla S, Chertow GM, Herzog CA; EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. J Am Heart Assoc. 2014 Nov 17;3(6):e001363. doi: 10.1161/JAHA.114.001363.
157. Wesseling C, Aragón A, González M, Weiss I, Glaser J, Bobadilla NA, Roncal-Jiménez C, Correa-Rotter R, Johnson RJ, Barregard L. Kidney function in sugarcane cutters in Nicaragua - A longitudinal study of workers at risk of Mesoamerican nephropathy.Environ Res. 2016 Feb 8;147:125-132.
158. Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, Loyola-Rodríguez G, Uribe-Uribe NO, Correa-Rotter R. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol. 2016 Feb 6. [Epub ahead of print]
159. Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM. Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. Clin J Am Soc Nephrol. 2015 Nov 27. pii: CJN.06370615. [Epub ahead of print]
160. Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial. Hemodial Int. 2015 Nov 13. doi: 10.1111/hdi.12382. [Epub ahead of print]
161. Torre A, Aguirre-Valadez JM, Arreola-Guerra JM, García-Flores OR, García-Juárez I, Cruz-Rivera C, Correa-Rotter R, Nino-Cruz JA. Creatinine Versus Cystatin C for Estimating GFR in Patients With Liver Cirrhosis. Am J Kidney Dis. 2016 Feb;67(2):342-4.
162. Mejía-Vilet JM, Córdova-Sánchez BM, Arreola-Guerra JM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R. Renal flare prediction and prognosis in lupus nephritis Hispanic patients. Lupus. 2015 Sep 24. pii: 0961203315606985. [Epub ahead of print]
163. Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A  Single-center Cohort Analysis. J Rheumatol. 2015 Nov;42(11):2082-91. doi: 10.3899/jrheum.150395. Epub 2015 Sep 15.
164. Ramirez-Sandoval JC, Casanova I, Villar-Tapia JA, Gomez FE, Cruz C, Correa-Rotter R BIOMARKERS ASSOCIATED WITH VASCULAR CALCIFICATION IN PERITONEAL DIALYSIS. Perit Dial Int. 2015 Aug 20. pii: pdi.2014.00250. [Epub ahead of print]
165. Schievink B, de Zeeuw D, Smink PA, Andress D, Brennan JJ, Coll B, Correa-Rotter R, Hou FF, Kohan D, Kitzman DW, Makino H, Parving HH, Perkovic V, Remuzzi G, Tobe S, Toto R, Hoekman J, Lambers Heerspink HJ. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. Eur J Prev Cardiol. 2015 Jul 30. pii: 2047487315598709. [Epub ahead of print]
166. Kohan DE, Lambers Heerspink HJ, Coll B, Andress D, Brennan JJ, Kitzman DW, Correa-Rotter R, Makino H, Perkovic V, Hou FF, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D. Predictors of Atrasentan- Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1568- 74.
167. Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa- Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; EVOLVE Trial Investigators. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Circulation. 2015 Jul 7;132(1):27-39.
168. Chang TI, Abdalla S, London GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Dehmel B, Goodman WG, Chertow GM.The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial. J Hum Hypertens. 2016 Mar;30(3):204-9.
169. Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9.
170. Prognostic significance of renal vascular pathology in lupus nephritis. Mejía-Vilet JM, Córdova-Sánchez BM, Uribe-Uribe NO, Correa-Rotter R, Morales-Buenrostro LE. Lupus. 2017 Jan 1:961203317692419. doi: 10.1177/0961203317692419. [Epub ahead of print]
171. International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE). Caplin B, Jakobsson K, Glaser J, Nitsch D, Jha V, Singh A, Correa-Rotter R, Pearce N. BMC Nephrol. 2017 Jan 3;18(1):1.
172. The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy. Pena MJ, de Zeeuw D, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Kohan DE, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, Sharma S, Corringham T, Sharma K, Heerspink HJ. Diabetes Obes Metab. 2016 Dec 25. doi: 10.1111/dom.12864. [Epub ahead of print]
173. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Schiffmann R, Hughes DA, Linthorst GE, Ortiz A, Svarstad E, Warnock DG, West ML, Wanner C; Conference Participants.. Kidney Int. 2017 Feb;91(2):284-293. doi: 10.1016/j.kint.2016.10.004. Epub 2016 Dec 18.
174. Comparison of exposure response relationship of atrasentan between North American and Asian populations. Heerspink HJ, Makino H, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Davis JW, Idler K, Kohan DE, Liu M, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D. Diabetes Obes Metab. 2017 Apr;19(4):545-552.
175. Heat stress, hydration and uric acid: a cross-sectional study in workers of three occupations in a hotspot of Mesoamerican nephropathy in Nicaragua.Wesseling C, Aragón A, González M, Weiss I, Glaser J, Rivard CJ, Roncal-Jiménez C, Correa-Rotter R, Johnson RJ. BMJ Open. 2016 Dec 8;6(12):e011034. Erratum in: BMJ Open. 2017 Jan 25;7(1):e011034corr1.
176. Dissonant health transition in the states of Mexico, 1990-2013: a  systematic analysis for the Global Burden of Disease Study 2013. Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, Correa-Rotter R, Rivera JA, Barquera S, González-Pier E, Aburto-Soto T, de Castro EF, Barrientos-Gutiérrez T, Basto-Abreu AC, Batis C, Borges G, Campos-Nonato I, Campuzano- Rincón JC, de Jesús Cantoral-Preciado A, Contreras-Manzano AG, Cuevas-Nasu L, de la Cruz-Gongora VV, Diaz-Ortega JL, de Lourdes García-García M, Garcia-Guerra A, de Cossío TG, González-Castell LD, Heredia-Pi I, Hijar-Medina MC, Jauregui A, Jimenez-Corona A, Lopez- Olmedo N, Magis-Rodríguez C, Medina-Garcia C, Medina-Mora ME, Mejia-Rodriguez F, Montanez JC, Montero P, Montoya A, Moreno- Banda GL, Pedroza-Tobías A, Pérez-Padilla R, Quezada AD, Richardson- López-Collada VL, Riojas-Rodríguez H, Ríos Blancas MJ, Razo-Garcia C, Mendoza MP, Sánchez-Pimienta TG, Sánchez-Romero LM, Schilmann A, Servan-Mori E, Shamah-Levy T, Téllez-Rojo MM, Texcalac-Sangrador JL, Wang H, Vos T, Forouzanfar MH, Naghavi M, Lopez AD, Murray CJ, Lozano R. Lancet. 2016 Nov 12;388(10058):2386-2402.
177. Clinical, Dialytic, and Laboratory Factors Associated With Poor Health-Related Quality of Life in Mexican Patients on Hemodialysis.Dehesa-López E, Correa-Rotter R, Olvera-Castillo D, González-Parra C, Baizabal-Olarte R. Rev Invest Clin. 2016 Jul- Aug;68(4):192-200.
178. In reply to: "Should we consider renaming 'Mesoamerican Nephropathy' as Nephropathy of Unknown Cause in Agricultural Labourers (NUCAL)?" García-Trabanino R, Jakobsson K, Guzmán Quilo C, Brooks DR, Crowe J, Barnoya J, Madero M, González Quiroz M, Wesseling C, Wegman DH, Correa-Rotter R. Occup Environ Med. 2016 Nov;73(11):802-803.
179. Authors' Response to "Letter to the Editor re: 'Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A  Theoretical Model and Systematic Review'" by Zubieta-Calleja et al. (High Alt Med Biol 2016;17:240). Ramirez-Sandoval JC, Castilla-Peon MF, Correa-Rotter R. High Alt Med Biol. 2016 Sep;17(3):241-242.
180. Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population. Mejía-Vilet JM, Córdova- Sánchez BM, Uribe-Uribe NO, Correa-Rotter R. Clin Rheumatol. 2016 Sep;35(9):2219-27.
181. Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes: A Case-Control Study. Barrera-Vargas A, Rosado-Canto R, Merayo-Chalico J, Arreola-Guerra JM, Mejía-Vilet JM, Correa-Rotter R, Gómez-Martín D, Alcocer-Varela J. J Clin Rheumatol. 2016 Aug;22(5):235-40.
182. Transcultural adaptation and validation of the Mexican version of the kidney disease questionnaire KDQOL-SF36 version 1.3. Dehesa- López E, Correa-Rotter R, Olvera-Castillo D, González-Parra C, Baizabal- Olarte R, Orozco-Vega R. Qual Life Res. 2017 Jan;26(1):193-198.
183. Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy. Glaser J, Lemery J, Rajagopalan B, Diaz HF, García-Trabanino R, Taduri G, Madero M, Amarasinghe M, Abraham G, Anutrakulchai S, Jha V, Stenvinkel P, Roncal-Jimenez C, Lanaspa MA, Correa-Rotter R, Sheikh- Hamad D, Burdmann EA, Andres-Hernando A, Milagres T, Weiss I, Kanbay M, Wesseling C, Sánchez-Lozada LG, Johnson RJ. Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1472-83.
184. Bicarbonate Values for Healthy Residents Living in Cities Above 1500 Meters of Altitude: A Theoretical Model and Systematic Review. Ramirez-Sandoval JC, Castilla-Peón MF, Gotés-Palazuelos J, Vázquez- García JC, Wagner MP, Merelo-Arias CA, Vega-Vega O, Rincón-Pedrero R, Correa-Rotter R. High Alt Med Biol. 2016 Jun;17(2):85-92.
185. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, Köttgen A, Kretzler M, Levey AS, Luyckx VA, Mehta R, Moe O, Obrador G, Pannu N, Parikh CR, Perkovic V, Pollock C, Stenvinkel P, Tuttle KR, Wheeler DC, Eckardt KU; ISN Global Kidney Health Summit participants. Lancet. 2017 Apr 20. pii: S0140- 6736(17)30788-2.
186. A Simple Risk Score for Prediction of Hemorrhagic Complications after a Percutaneous Renal Biopsy. Mejía-Vilet JM, Márquez-Martínez MA, Cordova-Sanchez BM, Chapa Ibargüengoitia M, Correa-Rotter R, Morales-Buenrostro LE. Nephrology (Carlton). 2017 Apr 16. doi: 10.1111/nep.13055. [Epub ahead of print]
187. Recommended standards for assessing blood pressure in human research where blood pressure or hypertension is a major focus. TRUE Consortium. J Hum Hypertens. 2017 Apr 13. doi: 10.1038/jhh.2017.10
188. Contemporary Dietary Intake: Too Much Sodium, Not Enough Potassium, yet Sufficient Iodine: The SALMEX Cohort Results. Vega- Vega O, Fonseca-Correa JI, Mendoza-De la Garza A, Rincón-Pedrero R, Espinosa-Cuevas A, Baeza-Arias Y, Dary O, Herrero-Bervera B, Nieves- Anaya I, Correa-Rotter R. Nutrients. 2018 Jun 25;10(7). pii: E816. doi: 10.3390/nu10070816.
189. Long-term survival of kidney grafts in lupus nephritis: a Mexican cohort. Ramirez-Sandoval JC, Chavez-Chavez H, Wagner M, Vega-Vega O, Morales-Buenrostro LE, Correa-Rotter R. Lupus. 2018 Jul;27(8):1303-1311.
190. Baseline characteristics and enrichment results from the SONAR trial. Heerspink HJL, Andress DL, Bakris G, Brennan JJ, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray J, Perkovic V, Tobe S, Wigderson M, Yi T, Parving HH, de Zeeuw D. Diabetes Obes Metab. 2018 Mar 31. doi: 10.1111/dom.13315.
191. Relationship between Nutritional Status and Gastrointestinal Symptoms in Geriatric Patients with End-Stage Renal Disease on Dialysis. Carrera-Jiménez D, Miranda-Alatriste P, Atilano-Carsi X, Correa-Rotter R, Espinosa-Cuevas Á. Nutrients. 2018 Mar 29;10(4). pii: E425. doi: 10.3390/nu10040425.
192. Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy. Heerspink HJL, Andress DL, Bakris G, Brennan JJ, Correa- Rotter R, Dey J, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray J, Perkovic V, Tobe S, Wigderson M, Parving HH, de Zeeuw D. Diabetes Obes Metab. 2018 Jun;20(6):1369-1376. doi: 10.1111/dom.13245. Epub
193. Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: A  comparative cohort study. Meraz-Munoz A, Gomez-Ruiz I, Correa- Rotter R, Ramirez-Sandoval JC. J Crit Care. 2018 Apr;44:244-248. doi: 10.1016/j.jcrc.2017.11.022.
194. Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus. Jiménez IU, Díaz-Díaz E, Castro JS, Ramos JP, León MC, Alvarado Ríos JA, Auriostigue Bautista JC, Correa-Rotter R, Aguilar Salinas CA, Larrea F. Arch Med Res. 2017 May;48(4):360-369. doi: 10.1016/j.arcmed.2017.07.001.
195. Combined assessment of nutritional status in patients with peritoneal dialysis using bioelectrical impedance vectors and malnutrition inflammation score. Munoz-Pérez E, Espinosa-Cuevas MLÁ, Miranda-Alatriste PV, Correa-Rotter R, Atilano-Carsi X. Nutr Hosp. 2017 Oct 24;34(5):1125-1132. doi: 10.20960/nh.890.
196. Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial. Webb DJ, Coll B, Heerspink HJL, Andress D, Pritchett Y, Brennan JJ, Houser M, Correa-Rotter R, Kohan D, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Busch R, Pergola P, Parving HH, de Zeeuw D. Drugs R D. 2017 Sep;17(3):441-448. doi: 10.1007/s40268-017-0201-0.
197. Food Sources of Sodium Intake in an Adult Mexican Population: A  Sub-Analysis of the SALMEX Study. Colin-Ramirez E, Espinosa-Cuevas Á, Miranda-Alatriste PV, Tovar-Villegas VI, Arcand J, Correa-Rotter R. Nutrients. 2017 Jul 27;9(8). pii: E810. doi: 10.3390/nu9080810.
198. Complications of chronic kidney disease: current state, knowledge gaps and strategy for action. Aminu K. Bello, Mona Alrukhaimi, Gloria E. Ashuntantang, Shakti Basnet, Ricardo C. Rotter, Walter G. Douthat, Rumeyza Kazancioglu, Anna Kottgen, Masaomi Nangaku, Neil R. Powe, Sarah L. White, David C. Wheeler and Orson Moe. Kidney Int supplements 2017 7,122-129. 199.Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis. Chávez-Mendoza CA, Nino-Cruz JA, Correa-Rotter R, Uribe-Uribe NO, Mejía-Vilet JM. Kidney Int Rep. 2018 Aug 31;4(1):40-47. doi: 10.1016/j.ekir.2018.08.010.
200. Kidney disease in Latin America: current status, challenges, and the role of the ISN in the development of nephrology in the region. Pecoits-Filho R, Sola L, Correa-Rotter R, Claure-Del Granado R, Douthat WG, Bellorin-Font E; International Society of Nephrology Regional Board. Kidney Int. 2018 Dec;94(6):1069-1072. doi: 10.1016/j.kint.2018.07.026.
201. Development of a screening tool for a high sodium intake in an adult Mexican population. Miranda Alatriste PV, Ramírez EC, Guillén Hernández M, Rivera Mancía S, Cartas Rosado R, Espinosa-Cuevas Á, Correa-Rotter R, Vallejo M. Nutr Hosp. 2018 Oct 5;35(5):1163-1173. doi: 10.20960/nh.1789.
202. Development of an online tool for sodium intake assessment in Mexico. Colín-Ramírez E, Cartas-Rosado R, Miranda Alatriste PV, Espinosa Cuevas Á, Arcand J, Morales Guerrero JC, Cassis Nosthas L, Rivera-Mancía S, Vallejo Allende M, Correa-Rotter R. Rev Panam Salud Publica. 2019 Dec 6;43:e90. doi: 10.26633/RPSP.2019.90.
203. The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis. Scholtes RA, van Raalte DH, Correa-Rotter R, Toto RD, Heerspink HJL, Cain V, Sjöström CD, Sartipy P, Stefánsson BV. Diabetes Obes Metab. 2020 Apr;22(4):549-556. doi: 10.1111/dom.13923.
204. Chronic kidney diseases in agricultural communities: report from a workshop. Mendley SR, Levin A, Correa-Rotter R, Joubert BR, Whelan EA, Curwin B, Koritzinsky EH, Gaughan DM, Kimmel PL, Anand S, Ordunez P, Reveiz L, Rohlman DS, Scammell MK, Wright RO, Star RA. Kidney Int. 2019 Nov;96(5):1071-1076. doi:10.1016/j.kint.2019.06.024
205. Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE). Gonzalez-Quiroz M, Nitsch D, Hamilton S, O'Callaghan Gordo C, Saran R, Glaser J, Correa-Rotter R, Jakobsson K, Singh A, Gunawardena N, Levin A, Remuzzi G, Caplin B, Pearce N; DEGREE Study Steering Committee. BMJ Open. 2019 Sep 24;9(9):e031169. doi: 10.1136/bmjopen-2019-031169.
206. Pecoits-Filho R, Sola L, Correa-Rotter R, et al. Kidney disease in Latin America: current status, challenges, and the role of the ISN in the development of nephrology in the region. Kidney Int. 2018;94:1069- 1072. ] Kidney Int. 2019 Oct;96(4):1040. doi: 10.1016/j.kint.2019.08.002.
207. The authors reply. Pecoits-Filho R, Sola L, Correa-Rotter R, Claure- Del Granado R, Douthat WG, Bellorin-Font E. Kidney Int. 2019 Oct;96(4):1038-1039. doi:10.1016/j.kint.2019.06.012.
208. Survey on the perception of health professionals on the use of intradialytic oral nutrition in patients under hemodialysis. Ramos- Acevedo S, González-Ortiz AJ, Correa-Rotter R, Serralde-Zuniga AE, Miranda-Alatriste P, Atilano-Carsi X, Dominguez-Zambrano E, Espinosa-Cuevas Á. Rev Invest Clin. 2019;71(4):255-264. doi: 10.24875/RIC.19002947.
209. Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin. González-Ortiz A, Correa-Rotter R, Vázquez-Rangel A, Vega-Vega O, Espinosa-Cuevas Á. BMC Nephrol. 2019 Aug 14;20(1):316. doi: 10.1186/s12882-019-1457-0.
210. Mesoamerican Nephropathy. Correa-Rotter R, García-Trabanino R. Semin Nephrol. 2019 May;39(3):263-271. doi: 10.1016/j.semnephrol.2019.02.004.
211. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebocontrolled trial. Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140- 6736(19)30772-X
212. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744.
213. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial. Ramirez-Sandoval JC, Arvizu-Hernandez M, Cruz C, Vazquez-Cantu B, Rojas-Concha LJ, Tamez L, Reynerio F, Gomez FE, Correa-Rotter R. J Nephrol. 2019 Aug;32(4):645-659. doi: 10.1007/s40620-019-00599-x.
214. Comment on "Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology". Mejia-Vilet JM, Tejeda-Maldonado J, Correa-Rotter R. Reumatol Clin. 2020 Sep-Oct;16(5 Pt 2):433-434. doi: 10.1016/j.reuma.2018.07.011.
215. Mortality in Patients with Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy. Valdez-Ortiz R, Navarro-Reynoso F, Olvera-Soto MG, Martin-Alemany G, Rodríguez-Matías A, Hernández-Arciniega CR, Cortes-Pérez M, Chávez-López E, García-Villalobos G, Hinojosa-Heredia H, Camacho- Aguirre AY, Valdez-Ortiz Á, Cantú-Quintanilla G, Gómez-Guerrero I, Reding A, Pérez-Navarro M, Obrador G, Correa-Rotter R. Kidney Int Rep. 2018 Jun 20;3(5):1171-1182. doi: 10.1016/j.ekir.2018.06.004.
216. Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease. Koomen JV, Stevens J, Bakris G, Correa- Rotter R, Hou FF, Kitzman DW, Kohan DE, Makino H, McMurray JJV, Parving HH, Perkovic V, Tobe SW, de Zeeuw D, Heerspink HJL. Clin Pharmacol Ther. 2020 Dec 18. doi: 10.1002/cpt.2143.
217. Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease. McMurray JJV, Wheeler DC, Stefánsson BV, Jongs N, Postmus D, Correa-Rotter R, Chertow GM, Greene T, Held C, Hou FF, Mann JFE, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Heerspink HJL; DAPACKD Trial Committees and Investigators. Circulation. 2021 Feb 2;143(5):438-448. doi: 10.1161/CIRCULATIONAHA.120.051675. Epub 2020 Nov 13. PMID: 33186054
218. Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial. Koomen JV, Stevens J, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Parving HH, Perkovic V, Tobe SW, de Zeeuw D, Heerspink HJL. Diabetes Obes Metab. 2021 Feb;23(2):561-568. doi: 10.1111/dom.14252. Epub 2020 Nov 26. PMID: 33184931
219. Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome. Ramirez-Sandoval JC, Gaytan-Arocha JE, Xolalpa-Chávez P, Mejia-Vilet JM, Arvizu-Hernandez M, Rivero-Sigarroa E, Torruco-Sotelo C, Correa-Rotter R, Vega-Vega O. Blood Purif. 2020 Oct 26:1-9. doi: 10.1159/000510996. Online ahead of print.
220. Nutritional status, hyperkalaemia and attainment of energy/protein intake targets in haemodialysis patients following plant-based diets: a longitudinal cohort study. González-Ortiz A, Xu H, Ramos-Acevedo S, Avesani CM, Lindholm B, Correa-Rotter R, Espinosa-Cuevas Á, Carrero JJ. Nephrol Dial Transplant. 2020 Oct 6: gfaa194. doi: 10.1093/ndt/gfaa194.
221. Dapagliflozin in Patients with Chronic Kidney Disease. Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816.
222. Correction of anemia by dapagliflozin in patients with type 2  diabetes. Stefánsson BV, Heerspink HJL, Wheeler DC, Sjöström CD, Greasley PJ, Sartipy P, Cain V, Correa-Rotter R. J Diabetes Complications. 2020 Dec;34(12):107729. doi: 10.1016/j.jdiacomp.2020.107729. Epub 2020 Sep 5. PMID: 32948397
223. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Wheeler DC, Stefansson BV, Batiushin M, Bilchenko O, Cherney DZI, Chertow GM, Douthat W, Dwyer JP, Escudero E, Pecoits-Filho R, Furuland H, Górriz JL, Greene T, Haller H, Hou FF, Kang SW, Isidto R, Khullar D, Mark PB, McMurray JJV, Kashihara N, Nowicki M, Persson F, Correa-Rotter R, Rossing P, Toto RD, Umanath K, Van Bui P, Wittmann I, Lindberg M, Sjöström CD, Langkilde AM, Heerspink HJL. Nephrol Dial Transplant. 2020 Oct 1;35(10):1700-1711. doi: 10.1093/ndt/gfaa234.
224. Global kidney exchange should expand wisely. Roth AE, Marino IR, Ekwenna O, Dunn TB, Paloyo SR, Tan M, Correa-Rotter R, Kuhr CS, Marsh CL, Ortiz J, Testa G, Sindhwani P, Segev DL, Rogers J, Punch JD, Forbes RC, Zimmerman MA, Ellis MJ, Rege A, Basagoitia L, Krawiec KD, Rees MA. Transpl Int. 2020 Sep;33(9):985-988. doi: 10.1111/tri.13656. PMID: 32430941
225. Prevalence of thyroid dysfunction in healthy adults according to the estimated iodine intake in 24-hour urine samples: The SALMEX cohort. Flores-Rebollar A, Pérez-Díaz I, Vega-Vega O, Rivera-Moscoso R, Fagundo-Sierra R, Carbajal-Morelos SL, Osorio-Landa HK, López- Carrasco MG, Lira-Reyes AR, Correa-Rotter R. Eur J Nutr. 2021 Feb;60(1):399-409. doi: 10.1007/s00394-020-02254-9. Epub 2020 May 3.
226.Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units. Vega-Vega O, Arvizu-Hernández M, Domínguez-Cherit JG, Sierra-Madero J, Correa-Rotter R. Salud Publica Mex. 2020 May-Jun;62(3):341-347. doi: 10.21149/11330.
227. Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial. Heerspink HJL, Stefansson BV, Chertow GM, Correa- Rotter R, Greene T, Hou FF, Lindberg M, McMurray J, Rossing P, Toto R, Langkilde AM, Wheeler DC; DAPA-CKD Investigators. Nephrol Dial Transplant. 2020 Feb 1;35(2):274-282. doi: 10.1093/ndt/gfz290. PMID: 32030417 Free PMC article.
228.New 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Martínez-Rueda AJ, Olivas- Martínez A, Vega-Vega O, Fonseca-Correa JI, Correa-Rotter R. Hypertension. 2019 Jan;73(1):142-147. doi: 10.1161/HYPERTENSIONAHA.118.11827.
229. Clinical Factors Associated with Early and Persistent Hypocalcemia After Parathyroidectomy in Patients on Dialysis with Severe Hyperparathyroidism.Fonseca-Correa JI, Nava-Santana C, Tamez-Pedroza L, Paz-Cortes A, Santillan-Ceron A, Rojas-Concha LJ, Pantoja-Millán JP, Sierra-Salazar M, Velazquez-Fernández D, Herrera MF, Correa-Rotter R, Ramirez-Sandoval JC. Nephrology (Carlton). 2021 Jan 27. doi: 10.1111/nep.13854. Online ahead of print. PMID: 33502071
230. The Role of the Unfolded Protein Response on Renal Lipogenesis in C57BL/6 Mice. Figueroa-Juárez E, Noriega LG, Pérez-Monter C, Alemán G, Hernández- Pando R, Correa-Rotter R, Ramírez V, Tovar AR, Torre-Villalvazo I, Tovar-Palacio C. Biomolecules. 2021 Jan 7;11(1):73. doi: 10.3390/biom11010073. PMID: 33430288 Free PMC article.
231. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.Wheeler DC, Stefánsson BV, Jongs N, Chertow GM, Greene T, Hou FF, McMurray J JV, Correa-Rotter R, Rossing P, Toto RD, Sjöström CD, Langkilde AM, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Lancet Diabetes Endocrinol. 2021 Jan;9(1):22-31. doi: 10.1016/S2213-8587(20)30369-7. PMID: 33338413 Clinical Trial.
232. Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.Chertow G, Vart P, Jongs N, Toto R, Gorriz JL, Hou FF, McMurray J, Correa- Rotter R, Rossing P, Sjöström CD, Stefánsson B, Langkilde AM, Wheeler D, Heerspink H. J Am Soc Nephrol. 2021 Jul 16:ASN.2021020167. doi: 10.1681/ASN.2021020167. Online ahead of print. PMID: 34272327
233. Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline. Stefánsson BV, Heerspink HJL, Wheeler DC, Sjöström CD, Greasley PJ, Sartipy P, Cain V, Correa-Rotter R. Data Brief. 2021 Jun 21;37:107237. doi: 10.1016/j.dib.2021.107237.
234. Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A  Prespecified Analysis From the DAPA-CKD Trial. Persson F, Rossing P, Vart P, Chertow GM, Hou FF, Jongs N, McMurray JJV, Correa-Rotter R, Bajaj HS, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Diabetes Care. 2021 Jun 28:dc210300. doi: 10.2337/dc21-0300. Online ahead of print. PMID: 34183431
235. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy. Wheeler DC, Toto RD, Stefánsson BV, Jongs N, Chertow GM, Greene T, Hou FF, McMurray JJV, Pecoits-Filho R, Correa- Rotter R, Rossing P, Sjöström CD, Umanath K, Langkilde AM, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Kidney Int. 2021 Jul;100(1):215-224. doi: 10.1016/j.kint.2021.03.033. Epub 2021 Apr 18.
236. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. Heerspink HJL, Sjöström CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa- Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Eur Heart J. 2021 Mar 31;42(13):1216-1227. doi: 10.1093/eurheartj/ehab094. PMID: 33792669
237. Community- and Hospital-Acquired Acute Kidney Injury in COVID- 19: Different Phenotypes and Dismal Prognosis. Martínez-Rueda AJ, Álvarez RD, Méndez-Pérez RA, Fernández-Camargo DA, Gaytan-Arocha JE, Berman-Parks N, Flores-Camargo A, Comunidad-Bonilla RA, Mejia- Vilet JM, Arvizu-Hernandez M, Ramirez-Sandoval JC, Correa-Rotter R, Vega-Vega O. Blood Purif. 2021 Mar 19:1-11. doi: 10.1159/000513948. Online ahead of print. PMID: 33744901
238. Frequency of Intradialytic Hypotension Events Do Not Increase with Oral Nutritional Supplementation during Hemodialysis Treatment: A Randomized Controlled Trial. Ramos-Acevedo S, González-Ortiz A, Serralde-Zúniga AE, Colín-Ramírez E, Miranda- Alatriste P, López-Cisneros S, Rodríguez-González N, Correa-Rotter R, Atilano-Carsi X, Espinosa-Cuevas Á. J Ren Nutr. 2021 Feb 26:S1051- 2276(20)30283-1. doi: 10.1053/j.jrn.2020.10.002. Online ahead of print. PMID: 33648870.

PUBLICACIONES DESTACADAS
Autora de capítulos de libros de Terapia Intensiva y Emergencias

PUBLICACIONES DESTACADAS
Cabarrou A, Schaposnik F, Costa Gil JE, et al.
The small intestine in diabetes mellitus. Correlation of clinical phenomena to histomorphometric findings in peroral biopsy material.Acta Diabetol Lat. 1975;12:9-23

Costa Gil JE, Galloway JA, Wentworth SM. Tratamiento de diabéticos con la bomba Auto-Syringe para la infusión continua de insulina por vía subcutánea. Rev Clin Esp. 1982;164:377-381.

Costa Gil JE, Touceda LA, Pianzola H, et al. Estudio histopatológico y funcional del rinón en la diabetes no insulino-dependiente. Medicina (B Aires). 1994;54:289-300.

Gagliardino JJ, Costa Gil JE, Faingold MC, et al Insulina y control de la diabetes en la Argentina.
Medicina (B Aires). 2013;73:520-528.

Costa Gil JE, Linari MA, Pugnaloni N, et al. Hipoglucemia en pacientes con diabetes mellitus tipo 1 y tipo 2 con insulinoterapia. Resultados del estudio HAT global en Argentina. Medicina (B Aires). 2017;77:449-457.

Litwak LE, Querzoli I, Musso C, Dain A, Houssay S, Proietti A, Costa Gil JE. Monitoreo continuo de la glucosa. Utilidad e indicaciones. Medicina (B Aires). 2019;79:44-52.

PUBLICACIONES DESTACADAS
López C.A., Couto E., Gularte A. Escorpionismo y primeros registros de Tityus trivittatus y Tityus serrulatus en Puerto Iguazú, provincia de Misiones. Rev Argent Salud Pública, 2019;10(40): 51-54
García, Julián; Seijo, Agustín; Benchetrit, Andrés; Couto, Esteban; Echazarreta, Sofía; Lloveras, Susana; Orduna, Tomás. "Malaria por Plasmodium vivax y falla al tratamiento radical". REVISTA CHILENA DE INFECTOLOGIA, 33 num.4 (2016): 468 - 471.
J García, G Cárdenas, E Couto, A Benchetrit, S Echazarreta, L Tadey, J Wallach. "Endocarditis Infecciosa de válvula tricúspide por Streptococcus sanguinis en paciente con ductus arterioso persistente cursando infección aguda por virus Epstein-Barr". Cardiología e hipertensión. Noticias del instituto de investigaciones cardiologicas “Prof. Dr. Alberto C. Taquini”, Facultad de Medicina, UBA-CONICET. Marzo 2015; 16; 11-16.